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ABSTRACT
Activation mechansm of the a-factor pheromone receptor of Saccharomyces cerevisiae was
analyzed using biochemical and genetic techniques. An in vitro paral proteolysis assay was
developed to determne the conformational change of the receptor that occurs upon binding of
agonist. The activation specific cleavages were established by comparng cleavage products with
antagonist versus agonist occupied receptor. Of the changes in peptide pattern that were revealed
by trpsinization, the fragment resulting from the exposure of the thd loop to the protease was
found to be agonist specific and to be G-protein independent. A low-affmity binding receptor
mutant was isolated which failed to undergo this agonist induced conformational change. Four
intra-allelic suppressors of this receptor mutant were isolated and all were mapped to the ends of
transmembrane helices 4, 5 , 6 and 7; all were found to be replacements of non-polar residues by
polar ones. The role of the suppressor mutations in conformational change was analyzed.
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INTRODUCTION
The superfamily of G-protein coupled receptors (GPCR) are responsible for transducing
signals in response to a number of diverse stimuli such as light, odorants,
neurotransmitters , peptide hormones, biogenic amnes , opiods and ions. Sequence of
these receptors suggests seven hydrophobic domains of sufficient length to span the lipid
bilayer (20-28 amno acids), hydrophilic intervening sequences, an extracellular N-termal
domain and an intracellular C-termnal tai, Figue lA. The presence of the seven
transmembrane-spanng segments is seen clearly by using high-resolution electton cryo-
microscopy with the retinal-linked bacteriorhodopsin (Henderson et al. 1990).
Bacteriorhodopsin is a light activated proton-pump that is not coupled to G-proteins and
occurs natually as two-dimensional crystals within the purle membranes of
Halobacterium halobium. Recently, using membrane-mietic matrces, highly ordered 3D
crystals of bacteriorhodopsin were obtained which allowed the determation of the X -ray
strctue of the molecu1e at 2.5 Angstroms and confirmed the predicted transmembrane
topology (Pebay-Peyrou1a et al. 1997). Two-dimensional electron crystallography of
bovine rhodopsin which is a member of the GPCR superfamly has confirmed this overall
structure (Schertler 1993), although the packing of the helices is apparently different. It is
assumed that these receptors undergo a conformational change upon binding of the agonist
and that the conformational change is then propagated to the G-protein. The altered G-
protein strcture results in the exchange of the bound GDP for GTP in the Ga subunit,
which causes the dissociation of Ga from the 
'Y subunits. The free Ga and G 'Y can
interact and regulate effector functions such as adenyl cyclase, phospholipase, cyclic GMP
phosphodiesterase and ion-channels that regulate K+or Ca++ (Hedin et al. 1993). The fact
that GPCRs couple to a wide varety of ligands and yet share the same strctue has led to
J'J'-
the idea that these receptors have a common activation mechansm. The initial step of
activation has ben diffcult to delineate since crystalization of membrane proteins is
problematic. Therefore, the work on the mechanism of conformational change of these
receptors has relied on other techniques.
Evidence for Lil:and-induced Conformational Chanl:e
In order to convert extracellu1ar stiuli into intracellu1ar response, it is accepted that
receptors undergo a conformational change upon binding of ligand. This conformational
change "tus on" the effectors which in tu trgger a signal. Most investigations of
GPCRs were pioneered by studying rhodopsin which is abundant in the rod cells of the
retina. Apar from its abundance, rhodopsin forms a spectrally distinct form upon
activation by light; this propert allows dissection of its mechansm of activation.
Although x-ray crystallographic strctures of GPCRs with and without ligand are
not curently available, other observations provide evidence for ligand-induced
conformational change. Limited proteolysis used to detect light-sensitive changes in
rhodopsin revealed that photobleached rhodopsin is more susceptible to digestion compared
to the unbleached pigment, suggesting that a conformational change resu1ts from the
phototransition (Kuhn et al. 1982; Pellcone et al. 1985b). Whereas photoexcitation was
found to inhbit the cleavage of C-termal tail of rhodopsin (Pellcone et al. 1985b; Kuhn
et al. 1982), residues in transmembranes 4 and 6 (TM4 and TM6 respectively) become
more susceptible to cleavage by CNBr (Pellcane et al. 1985a). Synthetic peptides derived
from rhodopsin inhibit its interaction with transducin. These results implicate the
intracellular regions of the receptor as playing an essential role in the interaction with the G-
protein and lead to the general ideas that the unliganded receptor is in a more compact form
and that the binding of agonist releases the intracellular regions to interact with the G-
protein (Boure 1997). Similarly, time resolved electron spin resonance (ESR)
spectroscopy of the cysteine residues in rhodopsin suggests that photoactivation induces a
conformational transition at the junction of TM3 and second intracellu1ar loop; this
transition coincides with the spectral appearance of metarhodopsin (Farahbaksh et al.
1993). Combination of site-directed mutagenesis and electron paramagnetic resonance
(EPR) spectroscopy were used to deduce the distances between pais of nitroxide-tagged
cysteine residues. By determning the distance between a fixed residue at the junction of
TM3 and the second intracellular loop (i2) and residues on TM6 before and afer
photobleaching, Farens et al. (1996) concluded that TM6 moves with respect to TM3.
The importance of ths rigid body movement was demonstrated by comparg the
properties of cysteine-containing mutants in the reduced and the oxidized states. The
mutant rhodopsin was found to activate transducin (OT) when the cysteine residues were
reduced and were free to rotate; however, when the cysteine residues were oxidized, the
mutant rhodopsin was unable to stimulate OT (Farens et al. 1996). Presumably, the
formation of the disulfide bond blocks the conformational transition.
Labeling of cysteine residues of the ~2-adrenergic receptors was informative as
well. In this case, cysteine-reactive fluorescent tags which are highly sensitive to the
polarity of the environment were used to show dose-dependent decreases in fluorescence
upon agonist binding. The decrease in fluorescence was found to correlate with the
effcacy of the agonist used. Antagonists on the other hand produced small but significant
increases in fluorescence (Gether et al. 1995). This implies that the labeled cysteine
residues are exposed to a more polar environment upon agonist binding and that this is due
to receptor activation and G-protein coupling since these changes are specific for the
agonist. Systematic labeling of the cysteine residues of ~2-adrenergic receptor localized
residues responsible for conformational change to TM 3 and 6 (Gether et al. 1997).
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Chimeras of a2 and adrenergic receptors which couple to Gi and Gs respectively were
used to identify the determnants of agonist and antagonist binding and G-protein coupling
(Kobilka et al. 1988).
The strctual changes associated with receptor activation have also been explored
by using a combination of molecular dynamc simulations and site-diected mutagenesis.
These studies investigate the role that the conserved Asp/Glu-Arg-Tyr sequence (junction
of TM3 and the second intracellu1ar loop) plays in maitaining the equilibrium between the
inactive (R) form and the active (R*) form of the receptor. The deprotonated asparic acid
in this motif was predicted to stabilze the R state of the alB-adrenergic receptor; consistent
with this prediction, mutagenesis ofD142 to alanne was found to result in high
constitutivity (Achara and Kar 1996). Furher dissection of the role of this residue in
rhodopsin suggested a more complex scenaro, since although D134A, D134Q and D134I
were constitutive, D134F was not. These results imply that a combination of charge and
side chain-packing at ths junction infuence the inactive state of rhodopsin (Achara and
Karik 1996). These same researchers also found that R135 in this motif was not
responsible for binding of rhodopsin to transducin (OT) but rather for triggering GDP
release from transducin. Using the same combination of technques, (Scheer et al. 1996)
found that R143 is tucked into a polar pocket formed by the residues on TM1 , 2 and 7;
disruption of these interactions resulted in constitutivity. Spontaneous mutations that affect
the GPCRs and lead to disease have also been useful in understanding the role of these
residues as well as other residues in TM2 , TM3 , TM6 and TM7. These spontaneous
mutations have also drawn attention to unexpected regions of the receptor such as the
extracellular loops that apparently affect receptor activation (Birbaumer 1995).
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Receptor- protein complexes have been immunoprecipitated with antibodies
against both G-proteins and the receptor itself, and the effect of agonists or antagonists on
co-imunoprecipitation has been evaluated. Resu1ts from these studies provide the basis
for the hypothesis that the receptor isomerizes to the active form even in the absence of
agonist and that the binding of agonists and antagonists result in the stabilzation of the
active and the inactive states, respectively (Matesic and Luth 1991). The abilty of the
unliganded receptor that is in the inactive form (i.e. , uncoupled from G-proteins) to
isomerie to the activated form (i.e., able to couple with G-proteins) is consistent with the
basal levels of signalling (so-called "noise ) observed for G-protein coupled receptor
systems. The level of noise vares among the receptor systems; for example rhodopsin
produces very low noise levels (which allows a large number of receptors per cell),
whereas TSH shows much higher noise levels (Para et al. 1995). The addition of agonist
is thought to stabilze the activated form and lead to the formation of a ternar complex
(HRG) containing agonist, receptor and G-protein. The ratio of signal (HRG) to noise
(RG) determnes the strength of the signal. Thus, the activation of the receptor requires
thee processes: binding of agonist, conformational change and coupling to G-protein.
Information regarding the receptor wil be reviewed in term of the domains that are
responsible for these three functions.
and Bindinl: Domains
The receptors that belong to the superfamly of GPCRs can be subdivided into
receptors that bind either small molecu1es (such as biogenic amnes and retinal), peptides or
large glycoproteins. Among the GPCRs that bind amnes , ~2-adrenergic receptor is one of
the most extensively studied. The initial scanning deletion experiments with this receptor
showed the hydrophilic loop regions as unimportant for ligand binding (Dixon et al. 1987)
and therefore implicate the transmembrane regions. As a general strategy, conserved
residues of receptors that bound different ligands were ruled out as being important for
ligand binding. To fuer narow in on the specific residues involved in ligand binding,
polar residues in the transmembrane regions were selected for mutagenesis. Since all the
agonists and the antagonists of the adrenergic receptors are basic amnes , it was suspected
that there would be an acidic residue on the receptor that would act as the counter-ion for
the amne group. The mutagenesis of the two asparic acid residues in TM2 and TM3 of
the ~-adrenergic receptors was found to affect Kc and EC50 but to varing degrees;
whereas the Asp79A1a mutation increased both parameters by lO-fold, mutagenesis of
Asp113Glu resulted in an increase of 40,000 and 1,500-fold respectively. In contrast to
the wide conservation of the Asp79 residue, Asp 113 is conserved only among the receptors
that bind amne ligands suggestig that both residues are involved in ligand binding
through different mechansms; while the Asp 113 provides the counterion that interacts with
ligand, the Asp79 is likely to be necessar in maintaining the conformation of the agonist-
bound receptor (Strader et al. 1988). Apar from these residues, the disulfide bond
between the extracellular cysteines on most GPCRs is believed to be important for
stabilization of receptor strctue and the ligand binding pocket (Noda et al. 1994).
Rhodopsin, the first GPCR to be cloned, and the thrombin receptors are unlike the
rest of the superfamly in that they are both pre-coupled with their ligands. Rhodopsin has
a covalently bound ligand (retinal) that is buried in the TM domain. Retip.al form a Schiff
base with a lysine residue (296) in TM7, and glutamc acid 113 in TM3 provides the
counterion that interacts with the protonated retinal (Probst et al. 1992). The covalent
binding of ligand results in increased occupancy of the receptor, which wil ensure efficient
detection of an incoming photon and decrease noise that arises from opsin. The activation
of the thrombin receptor by thrombin is achieved through a different mechanism. The first
41 amino acids of the thrombin receptor is proteolyzed by thrombin; the new N -termnus
interacts with the binding pocket and activates the receptor (Birbaumer 1995).
Generalization regarding the position of ligand binding sites in GPCRs have been derived
from the analysis of mutant receptors as shown in Figure IB (Coughlin 1994). Receptors
with relatively smaliligands such as seratonin , histamine, catecholamnes bind to the
hydrophobic pocket. Larger ligands such as peptide hormones, endothelin, IL-8 and
neurokinin bind also to the extracellular portons of TM regions. Glycoprotein hormones
(TSH, FSH, LH/CG) and thyrotropin use the extracellular loops and the N-termnal tail
along with the transmembrane pocket. The ligands that bind the N-termnus are Glutamate
and Ca+ 2 , as well as thombin. The overall conclusion of work in this area is that the site
to which the agonist binds is not important; the activating function of the ligand is stil
exerted at the level of the transmembrane domain of receptors. Curent thought is that
agonists function by stabilizing an active conformation of the receptor that is present as
only a minor species in the absence of ligand (Schwar and Rosenklde 1996).
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Figure 1A. The general organiation of the GPCRs. The amino-termnus and the 3 extracellular loops
(e1-e3) face the extracellular side while the carboxy-terminus and the 3 intracellular loops (il-i3) face
the intracellular side of the cell.
Figure 1B. Diverse strategies for ligand detection by GPCRs. From S. Coughlin , 1994.
Activation Domains
GPCRs consist of hundreds of amno acids which can assume multiple molecular
strctures which wil be altered upon binding of ligand. Although ligand binding might
result in many changes in the overall structure of the receptor, the changes associated with
receptor activation are those that lead to productive interaction with G-proteins. Some of
the interactions important for activation have been deduced for rhodopsin. It has been
concluded that the inactive R state of rhodopsin which is not capable of activating
transducin is bonded covalently to II-Gis-retinal through Lys296 and this association with
the R state is stabilzed by the salt bridge with Glul13 in TM3. The R* state which
activates transducin lacks the salt bridge and binds preferentially to al-trans-retial.
Likewise, the angiotensin ATIA receptor is constrained through specific residues on TM3
(Asnl11) and TM7 (Asn295) which are believed to be in close spatial proximity as
determned by molecu1ar modeling. Disruption of ths interaction by mutant receptors
affecting either residue resulted in no detectable binding with antagonist and only high-
affinity binding with agonists, high-affinity binding was G-protein independent. The
mutant receptors had increased basal levels of signalling as compared to wild-type receptor.
This suggests that the interaction between these TM helices are important in maitaining the
receptor in the inactive state and that disruption of ths interaction leads to activation. These'
residues in the ATIA receptor are comparable to the Glul13 in TM3 and to Lys296 in TM7
of the rhodopsin, that is, mutation of either residue causes constitutivity. These residues
in rhodopsin are two and one helical turn above the Asnll1 and Asn295 respectively. A
residue that has an equivalent position to that of Asnl11 in the ATIA receptor is Cys128 in
TM 3 of the alB-adrenergic receptor. Substitution of this residue to phenylalanine was
found to cause constitutive activation of the phospholipase C pathway (Balmforth et al.
1997). These results reinforce the idea that the unliganded receptor is in a more constrained
conformation and that binding of ligand relaxes the receptor by disruption of the specific
, ..!'
intramolecular interactions. These findings provide an explanation as to why GPCRs are
susceptible to constitutive activation by mutations that are not localized to the same region;
any mutation that results in a "looser" conformation can lead to constitutivity (Bourne
1997).
protein Coupline Domains
It has been shown that one-thid of the uniganded a2-adrenergic receptors in the
cell are found physically associated with the G-protein, and the remaining population of
receptors becomes coupled to the G-protein only after they have bound agonist (Neubig
1994). These findings are consistent with the notion that uniganded receptors isomerize to
the R * state capable of interacting with G-proteins and that binding of agonist stabilzes this
state and unmasks G-protein-binding sites. Work with chimeric receptors that couple to
two different G-proteins, Gs and Gi, implicate the thid intracellular loop of the receptor as
being one of the specific G-protein contacts. However, high effciency coupling requies
additional structual featues; some of these features are specified by the second intracellular
loop (Hedin et al. 1993). Recently, it has been shown that the second intracellular loop 
important for coupling to both Gi and Gs, and the third intracellular loop contains two
potent coupling domains: one of these domains is sufficient for binding to Gi, whereas
both domains are required for binding to Gs (Eason and Liggett 1996). The
asparate/glutamate-arginne-tyrosine "D/ERY" motif in the C-termnal porton of the
second intracellular loop is important in coupling a subclass of receptors to G-proteins. A
naturally occurng variant contains a histidine instead of the arginine in this motif in the
VP2-vasopressin receptors. It was found to cause congenital nephrogenic diabetes
insipidus as a consequence of uncoupling the receptor and Gs (Rosenthal et al. 1993).
Substitution of the equivalent arginine in rhodopsin results in a mutant receptor that can
bind to, but not activate OT; these rhodopsin mutants presumably cannot induce the release
of the GDP from the heterotrimeric G-protein (Achara and Karik 1996). In addition to
these points of contact, the G-protein interaction of biogenic amne receptors, angiotensin
receptor and rhodopsin was found to also require the carboxy-termnal tail (Strader et al.
1994). Apar from intracellular regions of the receptor, mutations affecting the extracellular
loops have been found to cause constitutivity (Nanevicz et al. 1996) and (Perez et al.
1996). Apparently, changes in distant pars of the receptor can result in release of G-
protein from the coupling domain of the receptor.
Although GPCRs that bind simiar ligands possess common sequence motifs in
their ligand binding and the activaton domais, there are no common sequence motifs
among receptors that bind to the same G-proteins. For the receptor- protein interaction
importance of the overal tertiar strctue of the intracellular loops, as opposed to sequence
identity, has been implicated from coexpression of mamalian receptors in yeast. Prce et
al. (1996) have shown that the rat A2a adenosine receptor could be functionally coupled to
the pheromone pathway when expressed in Saccharomyces cerevisiae. This is surrising
since mamalian Gs and the yeast Ga homolog, GPAl share little sequence homology;
notably homology is lackig in the C-termnal region which is thought to interact with the
receptor. Moreover, the fact that these receptors share little sequence homology
underscores the importance of the higher order structural featues , rather than primar
sequence, in determning the coupling site (Price et al. 1996).
The Yeast a-Factor Pheromone Receptor
The pheromone receptor from Saccharomyces cerevisiae contains seven membrane-
spanning domains (Carwright, 1991) and is coupled to G-proteins (Blumer and Thorner
1990). The presence of a GPCR in yeast provides an experimental system where genetics
jJ,"
can be used to complement molecular and biochemical approaches. Yeast cells can exist
either as diploids or as haploids; haploid cells exist in one of two mating types, a and a.
The peptide pheromones a-factor (synthesized by a cells) and a-factor (synthesized by a
cells) bind to receptors located on the surace of haploid cells of the opposite mating type.
The receptors are cell-type specific proteins of the mating pathway and are encoded by the
STE2 and STE3 genes. Both receptors contain seven transmembrane segments and
require homo logs of the mamalian Ga, G~ and Gy protein subunits (encoded by the
GPAI , STE4 and STE18 genes, respectively) for their abilty to cause Gl arest of cell
division and to induce the expression of genes controllng the conjugation of the two cell
types (Marsh et al. 1991). The receptor appears to form a direct physical association with
these G-protein subunits since a-factor binds ste4 mutant cells more weaky (Jenness et al.
1987) and since it dissociates more rapidly from membranes assayed in the presence of
GTP analogs or when the membranes are prepared from gpaI, STE4Hpl or ste18 mutants
(Blumer and Thorner 1990). Other a-factor responses include receptor endocytosis
(Schandel and Jenness 1994), mating-parner selection (Jackson et al. 1991) and the
promotion of changes in cellular morphology (Konopka 1993). Neither a-factor nor its
receptor show homology to their counterpars in the opposite cell type; unlike a-factor, a-
factor is faresylated at its C-termnus. Although the pheromone response pathways for a
cells and a cells apparently use the same post-receptor gene products, the receptors show
no obvious sequence homology.
Com arison of STE2 with other GPCRs
Although a wealth of information has been gathered from the mamalian G-protein
coupled receptors using biochemical and biophysical approaches, yeast offers the
advantage of an in vivo system where genetic analysis can complement the biochemical
findings.
The yeast pheromone response pathway consists of a G-protein- coupled
pheromone receptor and a mating specific MA kiase cascade (Lberer et al. 1997).
Although neither of the pheromone receptors show sequence homology with the
mamalian receptors, they share the common strctual organzation in that they consist of
seven transmembrane spanng regions, as well as an extracellular N-termnus and a
cytoplasmic C-termnal tail (Carright and Tipper 1991). Although the Ste2p is not
stabilzed through disulfide bonds, and does not contain a palmitoyl modification at its
carboxy tail, as do the mamalian counterpars, it is glycosylated at its N-termnus and is
phosphorylated at its C-termnus (Blumer et al. 1988). The C-termnal tail is not required
for binding or for signalling (Konopka et al. 1988) but mediates desensitization through
phosphorylation of certain residues (Reneke et al. 1988) and (Chen and Konopka 1996).
As in mamalan receptors, the C-termnal tai is also involved in desensitization and
endocytosis which requires the DAKSS sequence (Rohrer et al. 1993; Zanolar et al.
1992).
As is the case with the mamalian receptors, the intracellular thid loop has been
implicated for interaction with G-proteins in yeast as well (Clark et al. 1994; Sprague and
Thorner 1992; Stefan and Blumer 1994). Binding ofthe agonist to the receptor resu1ts in a
conformational change which leads to the dissociation of G-proteins (Bukusoglu and
Jenness 1996); in yeast, it is the free G~y subunits that interact with the downstream
elements of the yeast pheromone pathway (Dietzel and Kurjan 1987; Whteway et al.
1989). As mentioned above, pheromone receptors possess no obvious sequence
homology to mamalian receptors; conserved residues in other GPCRs responsible for
ligand interaction (such as an Asp or Glu in TM3) or the activation motifs (such as the DRY
in the N-termnal portion of the second intracellular loop) are either not essential (Sommers
and Dumont 1997) or absent in the a-factor receptor. However, structural motifs for
coupling to G-proteins seem to be conserved in pheromone receptors since heterologous
expression of some mammalian receptors induce the pheromone response pathway in a
manner that is dependent on the mamalian receptor agonist (Price et al. 1996).
Whereas the matalian systems are complicated by the presence of mu1tiple types
of G-proteins, yeast has only one known G~y (Whteway et al. 1989) and two 
subunits; the GPAI gene product is the subunit that is involved in the pheromone response
(Dietzel and Kurjan 1987; Miyajima et al. 1987). Unlike the other G-protein subunits, the
GP A2 gene product is not haploid-specific and has been implicated in the activation of
adenylyl cyclase and invasion in yeast (Nakafuku et al. 1988). This suggests the
possibilty that there may be another G~y subunit that Gpa2p interacts with. Personal
communication from J. Hisch' s lab suggests that another GPCR in yeast interacts with
Gpa2p. Nevertheless , the mating pathway is not affected by the lack of the Gpa2p
(Nakaf et al. 1988). Another apparent difference from the mamalian system
regarding the G-proteins is that they are apparently limiting relative to the receptor since the
overexpression of Ste2 does not increase pheromone sensitivity (Konopka et al. 1988).
STE2 and bindin domains.
Through the employment of mutagenesis and chimeric receptors , it has been shown
that the transmembrane domains of the yeast pheromone receptor are involved in ligand
binding. Insertional mutagenesis of the second and fourh transmembrane helices of the
pheromone receptor show reduced binding to a-factor and are signallng defective
(Konopka and Jenness 1991). Analysis of chimeric receptors of S. cerevisiae and S.
kluyveri have also leads to the conclusion that the transmembrane segments of receptor are
important for binding of a-factor (Sen and Marsh 1995). The two non-contiguous
important for binding of a-factor (Sen and Marsh 1995). The two non-contiguous
domains of STE2 which include the fIrst and the thid extracellular loop and their associated
transmembrane helices are sufficient to change the specificity of the S. kluyveri receptor to
factor. Recent work from our laboratory has led to the fInding that residues on TM2
(Y98), TM3 (T131), TM4 (SI84) and TM7 (G273) are important for binding of agonist.
Mutations of these residues lead to at least lO-fold reduced a-factor binding; the levels of
protein at the plasma membrane were found to be normal (A. Yang and D.D. Jenness
unpublished observation).
STE2 conformational chan
A number of published observations pertain to the existence of a conformational
change in the a-factor pheromone receptor.
1. Phosphopeptides generated in the presence and absence of a-factor treatment resulting
from the paral digestion of 32P-labelled STE2 showed that most fragments had increased
radioactivity in the presence of a-factor. This was taken to indicate that a-factor causes a
conf?rmational change of the carboxy tail of the receptor that alters its accessibilty to
trpsin (Reneke et al. 1988). However, it is also possible that post-receptor signals may
activate a kinase which phosphorylates the Ste2p.
2. Mutagenesis of Ste2p yielded mutant forms of the receptor which were responsive to a
parial agonist and an antagonist. Mutations in the third intracellular loop were found that
make the receptor responsive to kluyveri factor and to the antagonist DesTrpl , Ala3-
factor (Stefan and Blumer 1994). Similarly, mutations in Ste2p were found that are deep
in the TM region that make the receptor responsive to antagonist and improved response to
kluyveri factor (Marsh 1992). This phenotype of responsiveness to parial agonist and
antagonist may reflect the disruption of the interactions that maintain the receptor in its
inactive form. As a result, the mutant receptor is thought to be in a parally relaxed state
such that binding of weak agonist can trgger activation.
3. Mutation of a proline residue to leucine on transmembrane segment 6 which is conserved
between yeast and mamalian GPCRs was found to lead to constitutive activation. Since
prolines are liely to introduce kinks in transmembrane helices and since the position of the
residue is close to the thid intracellular loop, it is thought that this mutation allows the
unliganded receptor to assume the activated state (Konopka et al. 1996).
rotein cou lin domains of STE2
A priori the intracllular loops and the C-termal tail are al possible sites for G-
protein coupling domains since they are exposed to the cytoplasm. As in mamalian
GPCRs , certain mutations affecting the third intracellular loop of the receptor were shown
to severely block its ability to couple with the G-protein and to generate an intracellular
signal (Schandel and Jenness 1994; Weiner et al. 1993). Unpublished observations from
our lab also implicate a role for the carboxy-tail of the receptor in interaction with the G-
proteins; a temperatue-sensitive destabilizing mutation in the Ga subunit leads to the
constitutive arest phenotype at 38 oC that is observed in gpal null mutants at all growth
temperatues. This phenotype is exacerbated in ste2 deletion mutants and in mutants that
produce receptors lacking the carboxy-termnal domain. One interpretation of these results
is that the presence of the receptor C-termnal tail leads to stabilization of the G-protein
subunits by a direct interaction (Schandel, K.A. and Jenness, D. D. , unpublished work).
Endoc tosis and Si nalln Functions of STE2
Work in yeast suggest that signals for endocytosis are caried on the third
intracellular loop and the carboxy-tail of the receptor. A mutant form of Ste2p has been
identified that contains 4 more residues than the wild-type receptor in the C-termnal portion
of the intracellular thd loop (i3); this mutant receptor is internalized faster than wild-type
in a ligand independent maner. Although this mutant has a higher affinity for agonist, it
does not resu1t in a constitutive phenotype (Stefan and Blumer 1994). Work from our lab
showed that a non-signalling mutant receptor had normal ligand-induced endocytosis
implying that the signals for endocytosis and signaling are not necessarily the same
(Schandel and Jenness 1994). The carboxy-termnus of the receptor is essential for basal
endocytosis (Schandel and Jenness 1994) and (Konopka et al. 1988) and for ligand-
induced endocytosis; Rohrer et al. (1993) have localzed a sequence in ths region
(DAKSS) that is a signal for endocytosis. It has been shown that endocytosis in yeast
does not require G-protein coupling, (Jenness and Spatrck 1986; Blinder et al. 1989;
Schandel and Jenness 1994; Zanolari et al. 1992); in mamalian systems , certain f3
adrenergic receptor mutants that couple inefficiently to G-proteins were shown to undergo
ligand-mediated endocytosis as well (Cheung et al. 1990).
ands of STE2
In general, receptor ligands can be classified into three groups: Full agonists, paral
agonists and antagonists. Full agonists bind to the receptor and elicit maxmal biological
response; they generally show G-protein- dependent high-affinity binding, whereas parial
agonists elicit a submaximal response and usually do not show G-protein dependent
binding (Samama et al. 1994). Antagonists are molecules that bind the receptor but do not
produce a biological response. There are two types of antagonists. Neutral antagonists
elicit no effect alone but compete for activation by agonists; they are thought to bind with
similar affinity to R and R* forms. Negative antagonists (also referred to as inverse
agonists) reduce the basal activity ofreceptors and they generally reduce the affinity of the
receptor for the G-protein. Negative antagonists are thought to have a greater affinity for
the R form of the receptor (Samama et aL 1994).
The only full agonist for the a-factor receptor is a-faCtor itself. Its sequence is
shown in Table 1. It is encoded by the two genes MFal and MFa2; these genes contain
four and two tandem copies respectively of the information encoding the a-factor peptide.
factor binds its receptor with an equilbrium dissociation constant (Kc) of 6 nM (Jenness
et al. 1986). The peptide is thought to contain a ~-bend that may be important for
bioactivity (Xue et al. 1996). It is also thought that the fIrst trptophan of the molecule
stabilzes the interaction with the receptor by increasing the hydrophobicity of the molecu1e.
factor is synthesized in a similar fashion to the mamalian peptide hormones, as
prepropoly-a-factor is processed by proteases before it is secreted. Its sequence is similar
to the mamalian gonadotropin-releasing hormone (GnR) also known as luteinizing
hormone releasing hormone, see table below, (Naider and Becker 1986). Using different
analogs of a-factor (Eriotou-Bargiota et al. 1992; Manfredi et al. 1996), it has been shown
that the N-termnal portion (residues 1 through 4) of the molecu1e is important for
signalling activity and the C-termnal porton is important for binding. Blumer and Thorner
(1990) found that the interaction of a-factor with the receptor is pH-dependent (i.e., pH 6
gives tighter binding than pH 8); this suggests either that a residue in a-factor requires
protonation or that the conformation of the ligand binding site is affected by pH.
Peptides that differ from a-factor at one or more positions have been shown to
serve as parial agonists or antagonists (Raths et al. 1988). In this study, two forms of a-
factor, (desTrpl-a-factor and Ala3-a-factor) were found to act as parial agonists. Double
substitution ofthese forms, (desTrpl Phe3-a-factor and desTrpl Ala3-a-factor) converts
them into antagonists in that they fail to induce normal pheromone responses (i.
morphogenesis and agglutination); competition binding studies confirm the conclusion that
these analogs are inactive and rie out the possibility that they have low activity which
would have been manfest at high ligand concentrations. Ayce Yesilaltay and Mig Cui
have shown that desTrpl,Ala3-a-factor binds a-cells 12S-fold more weaky than a-factor
in that the ECSO of a-factor is 8 nM, whereas antagonist's is 1000 nM. Another paral
agonist for this receptor is the a-factor from kluyveri; (Table 1). Although kluyveri
and cerevisiae do not interbreed, high concentrations of a-factor from kluyveri (10-
100 fold over that required for cerevisiae factor) induces agglutinabilty of
cerevisiae MATa cells (Marsh and Herskowitz 1988). The two parial agonists that
were also used in this thesis are AN-37 and AN-44 (table 1). These novel peptides were
identified in a genetic screen to study the strctue-function relationship of a-factor
(Manfredi et al. 1996).
Table 1.
Sequence of a-factor and its analogs
factor WHQLKPGQPMY
EHWSYGLRPGGonadotropin-releasing hormone
kluyveri factor WHWSFSKGEPMY
AN-37 (a-factor analog)
AN-44 (a-factor analog)
CRGPQLKPGQPMY
WHSLGGRQPMY
desTrp 1 ,Ala3-a-factor HALQLKPGQPMY
Desensitization mechanisms in east
A common feature of hormone regulated systems is that the continued presence of
agonist results in a waning of the response. This ligand-induced loss of responsiveness is
referred to as adaptation or desensitization. In mammalian GPCR systems, desensitization
mechansms are known that either limt receptor activity or cause inbition of post-receptor
steps in the response pathway. The sequestration and phosphorylation of the receptor
faciltates binding of arestins to the receptor and decrease its abilty to activate the post-
receptor signal. G~'Y subunits regulate receptor desensitization by potentiating the
translocation of ~-adrenergic receptor kiase from cytosol to the plasma membrane (Hedin
et al. 1993). Pathways that dampen the post-receptor signal act generally on the G-protein
subunits. Hydrolysis of the GTP bound to GPAlp is likely to reverse the activation of the
Ga subunit. Whle phosducins act on G~'Y, the "RGS" proteins (regulators of G-protein
signalling proteins) negatively regulate Ga subunits. The RGS proteins are evolutionarly
conserved among Saccharomyces cerevisiae, Caenorhabditis elegans and humans; the yeast
homolog is the pheromone inducible SS12 gene product. Mutations in SS12 cause greater
than 100-fold increase in pheromone sensitivity and result in the inability to adapt and
recover from pheromone-induced arest of cell division (Dahlman and Thorner 1997). In
yeast, the product of the SSTI gene is also involved in desensitization of MATa cells
through a completely different mechanism. This gene (also known as BARl) encodes a
protease that specifically degrades a-factor and, as a consequence, results in the dampening
of responsiveness in MATa cells (Sprague and Herskowitz 1981) and (Chan and Otte
1982).
Overexpression of certain genes in yeast were found to lead to resistance to 
factor induced arest of cell division. One of these genes is the Ga homologue, Gpal.
The gpalV 150 mutation which is analogous to the constitutively-active allele of ras,
accelerates the rate of recovery from pheromone. It has been found that this adaptation
pathway depends on the MSG5 gene , which is a protein phosphatase that inactivates FUS3
(a MAP kinase) (Doi et al. 1994). Other genes that inhbit responsiveness when
overproduced are SST2 KSSl and AFRI. The KSSI gene product is normally involved
in activation of the pheromone pathway. Unlike the other gene products mentioned thus
far, the AFRI gene product seems to act through the C-termnal of the pheromone receptor.
There is some redundancy in its function since deletion of AFRI does not lead to increased
sensitivity to a-factor as does the sst2 deletion. Although it interacts with the carboxy-tail
of the receptor, there is no homology to protein kinases and very little homology to arestin
(Konopka et al. 1995).
Yet another pathway for desensitization was demonstrated by Hisch and colleagues
(Hirsch and Cross 1993). This study shows that the STE3 gene (which encodes the a-
factor receptor normally expressed only in MATa cells) when expressed in MATa cells
reversed the constitutive-signalling phenotype of the gpal null allele. Inbition of the
post-receptor signal is thought to result from the sequestration of the free ~y subunits by
the STE3 gene product. This does not require a-factor, or the products of STE2, SS12 
KSSl; thus it appears to constitute a different desensitization mechanism.
The Ternary Complex Model
The Ternar Complex Model (TCM) depicted in Figure 2A is one of number of
models that have been used to explain the activation of G-proteins by GPCR's (Cotecchia
et al. 1990; Monod et al. 1965; Onaran and Costa 1997; Samama et al. 1993; Weber 1972).
The name ternar complex emphasizes the importance of the trmolecular complex between
agonist, receptor, and G-protein in the process of signal transfer. It states that the
interaction between the agonist and the receptor results in a form that can interact
productively with the G-protein. According to this model, the receptor exists in two
, "
dynamc states as reflected by changes in agonist affinity. The high-afnity state of the
receptor that is ultimately stabilized by the agonist is designated the GRH. The abilty of
agonists to promote this state depends on their greater affinity for the GR form than for the
R form of the receptor; this propert describes the efficacy or the intrsic activity of the
agonist. This model accounts for the abilty of GTP to convert the receptors from high
affinity state to the low affinity state.
Ternary complex model Exte nded model
weak
H+G+R RH+G
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t 51 
rang
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Figure 2. The ternary complex model and the extended model. H , G and
R are hormone , G prate in and receptor respective Iy. a and b are the coupling
consta nts while J, M and K are the isomerization consta nt, G prate 
association and agonist association equilbrium consta nts respective Iy.
The extended TCM model (Figue 2B) taes into consideration the isomerization
step of the receptor from the R to R * form. Only the R * form is capable of binding to the
protein. Direct evidence for the presence of R * state comes from recent work with
nicotinic acetylcholine receptor which is a gated channel which is not a GPCR. This work
demonstrates that the chanels open spontaneously in the absence of agonist and that the
signal is qualitatively and quantitatively not different from agonist-stimu1ated response.
The conductance of the chanel was observed even afer the disruption of the ligand
binding site and suggests that the molecule undergoes allosteric transitions, both in the
presence and absence of ligand (Jackson 1994).
Indication for isomerization of GPCRs to the R * state in the absence of ligand comes from
several observations:
Receptors with high and low affinity for agonists are present in the absence of G
nucleotides (Kent et al. 1980).
Receptors associate with G-proteins even in the absence of agonist (Okua and Reisine
1992).
0verexpression of ~-adrenergic receptors leads to an increase in the basal level of
signalling by increasing the number of receptors in the R * state (Samama et al. 1993;
Milano et al. 1994).
Constitutively activating mutations afecting the receptor result in increased affInity for
agonists even in the absence of G-proteins (Samama et al. 1993). Therefore, these
mutations result in a high-affinity, G-protein-independent state that canot be accounted for
by the simpler TCM model. According to the extended model, the constitutivity of the
mutant receptors is due to the increase in the isomerization constant; in other words, due to
their ability to adopt the R * form more easily in the absence of agonist.
In yeast, overexpression of Ste2p has been found to result in a lower-affnity form;
whereas the Kc in wild-type cells is 2-6 nM (Blumer, 1988; Jenness, 1986), the Kc in cells
containg mu1tiple copies of STE2 ranges from 12 nM (Blumer 1988) to 150 nM (Blumer
and Thorner 1990; David et al. 1997). These results suggest that in yeast, the availabilty of
the G-protein may limit the formation of the ternar complex. Since increased expression
of receptors affects the binding to a-factor (as indicated by Kc measurements), this could
also be interpreted to indicate that G-proteins were not limiting to begin with. This
apparent conflict can be settled when the relative ratio of the receptor to G-proteins is
determned in yeast. For most physiological systems, the number of G-proteins seems to
exceed the number ofthe receptors (Kenakn 1995; Neubig 1994). However, in in vitro
systems where the amount of G-protein is insufficient to permt coupling to an excess 
receptors, overexpression of ~-adrenergic receptor was found to resu1t in a low-affnity
state for ligand binding, similar to observations in yeast (Milano et al. 1994).
CHAPTER I
ALLOSTERIC TRANSITION OF THE YEAST PHEROMONE
RECEPTOR
An allosteric transition is a change in the binding or catalytc propertes of a
molecu1e brought about by the binding of an effector molecule at another site (Jackson
1994). The abilty of ligands to promote changes in protein conformation has been largely
pioneered by studying hemoglobin and allosteric enzymes (Ackers and Hazzard 1993;
Schachman 1988; Schumaher et al. 1995). In general, allosteric proteins are thought to
assume at least two conformational states that are in dynamc equibrium. Ligands that
activate the protein shift the equilibrium toward the more active state since they bind the
active conformation preferentialy; whereas, inbitors shift the equilbrium toward the
inactive state by binding preferentially to the inactive conformation (Monod et al. 1965).
The allosteric models that have been proposed for G-protein-coupled receptors predict that
agonists and certain antagonists (termed "inverse agonists ) shou1d have opposing effects
on receptor structue (Bond et al. 1995; Samama et al. 1993). Relatively little structual
information is known that pertains to the allosteric transitions in G-protein-coupled
receptors. Biophysical and biochemical investigations of rhodopsin suggest that
photoactivation leads to conformational changes at several sites in this protein, including
changes in the extradiscalloops (corresponding to intracellular loops) ; however, the
relationship of the conformational changes at these sites to G-protein activation remains
unclear (Fahy et al. 1995).
This chapter concerns ligand-induced conformational changes in the a-factor
pheromone receptor from the yeast Saccharomyces cerevisiae. Using parial trypsin
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digestion, it is shown that a-factor-induced conformational changes in the receptor result in
enhanced accessibilty of the thid intracellular loop, whereas the antagonist, desTrp 1 ,Ala3-
factor, reduces accessibility.
Materials and Methods
Yeast strains and culture conditions. All strains used are congenic with strain 381 
(Harell 1980). The genotype of strain DJ211- 3 (deposited in the American Type
Cultue Collection, ATCC 96515) is MATa cryl barl-l ade2-1 his4-580 leu2 lys2 trl tyrl
ura3 SUP4- Strain DJ903- l (Schandel and Jenness 1994) is identical to strain DJ211-
3 except that it contains mutation ste2- T326 (Konopka et al. 1988). Strain DJ803-
(provided by Jodi Hischman) is identical to strain DJ211- 3 except that it contains
mutation ste5- (Harell 1980) and mutation scgl::lacZ(LEU2) which disrupts the GPAI
gene (Dietzel and Kuran 1987). Cells were cultured in YM- l medium (Harwell 1967) at
C unless indicated otherwise.
tide li ands. a-factor (WHQLKPGQPMY) was obtained from Sigma Chemical
Co. (St. Louis, MO). The antagonist desTrpl,Ala3-a-factor (HALQLKPGQMY) was
synthesized and analyzed by Qualty Controlled Biochemicals (Hopkinton, MA); the
sequence was confIrmed by amno acid analysis and mass spectrometr.
Anal sis of artial tr sin di estion roducts. A cleared cellular lysate was
prepared as described previously (Schandel and Jenness 1994). Membranes were collected
by centrifugation (45 min , 140,000 x g); washed once with 1 mM magnesium acetate, 0.
mM dithiothreitol, 0. 1 mM EDTA, 7.6% glycerol and.10 mM MOPS , pH 7.0; and stored
at - C. Digestion of membranes (0.4 mg/ml protein) was intiated by adding TPCK-
treated trypsin (Sigma Chemical Co.) to 30 Jlg/ml at 30 C and termated by addig HCl to
016 N. In parallel reactions, 2 JlM synthetic a-factor was added prior to the addition of
trsin. Membranes (150 Jll from each time point) were collected by centrfugation in a
Beckman Airfuge, suspended in a solution of 1 % SDS and 1 % ~-mercaptoethanol (10 Jll);
incubated for 20 mi at C; and diluted 8-fold with 50 mM sodium phosphate buffer, pH
7. Asparagine-linked carbohydrate was removed with 20 mU of endoglycosidase H (2
hours, 37 C). Proteins were denatued by adding 50 Jll of SDS sample buffer (50 mM
Tris, pH6. 8, 0. 1 mM EDT A, 2% SDS, 0.01 % bromophenol blue, 10% glycerol; to this,
~-mercaptoethanol was added at 33 Jlllml) and incubated for 10 mi at C, resolved
electrophoretically on a 12% SDS-polyacrylamde gel, transferred to a PVDF membrane
(Millpore Corp, Bedford MA), probed with affinity-purified anti-receptor antiserum
diected agaist the N-termnal extracellu1ar domai (Konopka et al. 1988), and visualed
with the ECL chemiumiescent detection system (Amersham Life Science).
In vitro rotein s nthesis. Plasmids pJBK019 and pJBK020 (provided by James
Konopka; SUNY, Stony Brook) contain the coding region ofthe STE2 gene cloned into
the pGEMI and pGEM2 vectors, respectively. Plasmids were cleaved with Hind il, Cia
, Sty I, Nsi I or Eco RV and transcribed with either SP6 or T7 RNA polymerase
according to Promega Transcription in vitro Systems techncal manual intrctions (20 Jll of
5x transcription buffer, 10 JlllOO mM DTT, 0.5 mM rNTP, 2 Jlg DNA template, 50 U
RNA polymerase, 100 U RNAsin ribonuclease inhbitor and 0.5 U of yeast inorganic
pyrophosphatase in a final volume of 100 JlI with DEPC-treated water was incubated at
C for 2 hours). The RNA product was purified with sequential precipitations with 5M
LiCI and 70% ethanol (Sambrook et al. 1989). In vitro translation reactions containing
thionine utilzed either the wheat germ (full-length control and truncated proteins S
N and E, Fig. 1) or the rabbit reticulocyte lysate system (trncated protein C) as
recommended by the supplier (Promega Biotech). The translation products were resolved
on a single SDS-polyacrylamde gel together with trpsin-treated wild-type membranes
(strain DJ211- 3) and with ste2- T326 mutant membranes (strain DJ903-A-1), transferred
to a PVDF membrane, and probed with anti-receptor antibody as described above. The
radioactive translation products were detected by using autoradiography.
Results
Effect of factor on the rece tor cleava e sites. Limited trypsin digestion was
used to monitor ligand-induced conformational changes at multiple sites in the a-factor
receptor. The receptor contains 32 potential trpsin sites (Figure 1), whereas no sites are
present in a-factor. Initial attempts to cleave receptors on whole cells were unsuccessful
presumably because the two trpsin sites that are predicted to face the extracellular surace
are shielded either by the receptor conformation or by other cell-surace components. In
contrast, receptors in crude membrane preparations were cleaved readily. Figure 2 depicts
the electrophoretic analysis of the cleavage products that resulted from varing periods 
trpsin digestion. Since antiserum specific for an amno-termnal segment of the receptor
(Konopka et al. 1988) was used to detect these trptic fragments, their electrophoretic
mobilty reflects the relative distances of the varous cleavage sites from the amo-
termnus. The undigested sample contained two electrophoretic species corresponding to
the ful-length receptor (approximately 43 kD) and to a smaller fragment (35 kD) that
apparently resulted from cleavage during the membrane preparation (Figure 2, lanes 1 and
2). In the absence of a-factor, the receptor was cleaved within one minute to yield the
fragments designated Fl and F2 (lane 3). By five minutes, F2 was the predominant form
(lane 5). The cleavage events giving rise to fragment F3 were considerably slower (lane
;;',"'
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Figure 1. Primar strcture of the yeast pheromone receptor. Filed circles indicate potential trpsin cleavage
sites. Residues labeled E, N, S, and C indicate C termi predicted for the trncated receptors that were
synthesized in vitro. Mutation Ste2- T326 results in translational frameshift after residue 326 (labeled F) and
a protein product containing 334 residues (24).
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Figure 2. Influence of a-factor on the receptor cleavage pattern. Membranes were
incubated with trypsin for the number of minutes indicated in the presence or absence of
factor. The resulting cleavage products were analyzed by SDS-PAGE and immunoblotting
methods. The antiserum was agaist the N-termnus ofthe receptor (Konopka, 1988). The
control reaction was incubated for 100 minutes in the absence of trpsin and a-factor (lane
13). The major cleavage products (Fl, F2 , F3 and F4abc) are indicated at the right.
Molecular weights of the marker proteins are indicated at the left.
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7). Cleavage events close to the amno-termnus of the receptor eventualy gave rise to a
collection of smaller fragments designated F4a, b, and c (lanes 9 and 11) which were
resolved on 15% SDS-polyacrylamde gels with molecular weigths of about 18K, 16K and
running at the gel front respectively.
The binding of a-factor influences the rates at which cert trpsin sites are
cleaved. Fragment Fl persists slightly longer in the presence of a-factor (Figure 2
compare lanes 7 and 8), suggesting that the cleavage site giving rise to fragment F2 is
protected when a-factor is bound. Once F2 is formed, however, it is converted to
fragment F3 more rapidly in the presence of a-factor (lanes 5 though 8), indicating that the
site giving rise to F3 is more exposed in the agonist-occupied conformation. By 30 min,
the formation of F3 was essentialy complete in both the presence and the absence of a-
factor (lanes 9 and 10). When a-factor was present, F3 was relatively resistant to cleavage
in the presence of a-factor (compare lanes 11 and 12), indicating that the trpsin cleavage
sites giving rise to the F4 fragments are apparently protected by a-factor binding.
Although the overall rate of receptor digestion vared over a lO-fold range for different
membrane and trpsin preparations , a-factor consistently inhibited the formation of F2 and
accelerated the formation of F3 among the five independent experiments.
Protease digestion offers a powerfl phenomenological tool for detecting changes in
protein conformation. However, its usefulness for defining specific aspects of protein
conformation are subject to some limtations. First, the accumulation of a specific
intermediate is a function of the cleavage event that form it as well as the cleavages that
destroy it. The increased levels of fragment F3 that occur in the presence of a-factor are
apparently due to an increased rate of formation rather than decreased rates of destruction
since differential accumulation of F3 is apparent after only 1 and 5 minutes of digestion; at
these time points, the F4 fragments have not yet begun to accumulate. The second
limitation that complicates the kietic analysis is the potential influence of one cleavage
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event on the cleavage rate at a second site. Although I have not determned whether the
cleavage events in the assay are interdependent, the accelerated formation of fragment F3 is
unlikely to be an indiect consequence of prior cleavages, since a-factor produces only a
modest inhibition in formation of fragment F2, yet it dramatically stimulates formation of
F3. Moreover, as discussed below , the binding of an a-factor antagonist changes the
relationship of these two cleavage events. Thid, the steric restrctions that influence the
interaction of trpsin with a site on the receptor may be different from the restrctions that
govern interactions with the physiologically relevant molecu1es. Finaly, it is not possible
to detect slow cleavage events that occur at sites distal to rapid cleavage events.
Assi nment of tr sin cleava e sites. The trypsin cleavage sites were assigned to
positions in the priar strctue of the receptor by comparng electrophoretic mobilty of
the trptic fragments with receptor fragments of known lengt. Figure 1 shows the
potential trpsin cleavage sites and the positions of the carboxy-termnal residues of varous
trncated receptors (E, N, S , C and F). Full-length receptors that had been synthesized 
vitro (Figure 3, lane 4) migrated in the same position as those synthesized in vivo (lane 3).
Fragment F3 (lanes 1 , 2 and 9) was larger than synthetic receptors trcated at position 206
(trncation N, lane 7) yet smaller than synthetic molecules trncated at position 235
(trncation S, lane 6). Thus, the a-factor-stimulated cleavages that give rise to F3 occur in
or near loop i3 (position 225, 231, 233 or 234). Fragment F2 (lanes 1, 9 and 10) was
larger than synthetic receptors trncated at position 258 (trncation C, lane 5) and smaler
than the ste2- T326 mutant receptors (trncation F, lane 11), indicating that the a-factor-
inhbited cleavage occurs at the beginning of the carboxy-termnal cytoplasmic domain
(position 304 or 318). Fragment Fl was larger than the ste2- T326 mutant receptors,
indicating cleavage at or beyond position 337.
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Figure 3. Positions of the major receptor cleavage sites. Full-length receptors (lane 4) and the
. trncated receptors depicted in Fig. 1 (lanes 5, 6, 7 , and 8) were synthesized in vitro and resolved
by SDS-PAGE. Translation is predicted to termnate at residue 431 for full-length receptors, at
residue 259 for trncation C (lane 5), at residue 236 for trncation S (lane 6), at residue 204 for
trncation N (lane 7), and at residue 158 for trncation E (lane 8). Wild-type membranes (lanes 1-
9 and 10) and ste2- T326 mutant membranes (lane 11) were prepared and analyzed as in Fig. 2.
The membrane preparations were undigested (lanes 3 and 11) or digested for 1 min (lanes 1 and
10) or 10 rnn (lanes 2 and 9) with trpsin in absence (lanes 2, 10 and 11) or presence of a-factor
(lanes 1 and 9). All of the samples were visualized on a single SDS-PAGE gel that had been
tranerred to a PDVF fiter. The figue was generated by superimposing the autoradiographic
(lanes 4- 10) and the chemiluminescent images (lanes 1-3 and 9- 11). Positions of the major
cleavage products are indicated on the left.
Anal sis of mutant cells. The possible influence of the G-protein on the
conformational change was evaluated by examning the digestion pattern of membranes that
had been prepared from mutant cells lacking G-protein subunits. Specifically, I was
concerned that the increased rate of thid-loop cleavage upon a-factor bindig (Figue 2)
may have been a consequence of dissociation of the G-protein from the receptor rather than
a diect consequence of a receptor conformational change. When membranes were assayed
from gpal mutant cells that lack the Ga subunit (Figue 4A), a-factor both slowed the
formation of fragment F2 (lanes 5 and 6) and accelerated the formtion of fragment 
(lanes 5 though 10), as was observed for the wild-type strain (Figue 2). The overal
digestion rate was slower than that shown in Figue 2; however it was within the range that
we observed for wild-type membrane preparations. The additional digestion intermediate
that is larger than Fl (Figue 4A, lanes 3 and 4) was consistently observed with both wild-
type and mutant membrane when the overall digestion rate was slow. The effect of
factor was similar for the ste4 and ste 18 mutants lacking the G~ and Gy subunits
respectively (Figue 4B and C). I conclude that the a-factor-induced changes in the trtic
digestion pattern are not a simple consequence of G-protein dissociation and that the
a- factor sensitivity of the digestion pattern is likely to reflect conformational changes in the
receptor itself. I could not determne whether the G-protein deficiencies lead to small
differences in the overal digestion rate since the limitations of the assay permt only the
comparson of the effect of a-factor on the digestion of a given membrane preparation.
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Figure 4. Effects of G protein deletions on the cleavage pattern. (A) Membranes from the gpal
mutant were prepared and analyzed as described in Figure 2 , except that the strain contained the
temperature-sensitive mutation ste5- (Harwell , 1980) and was cultured at 34 C. These
conditions avoided the haploid-lethal phenotype exhibited by gpal mutants (Blinder, 1989). (B)
- .
Membranes from the 
ste4 mutation, and (C) membranes from the 
steIB mutation were prepared
. d analyzed as described in Figure 2.
The ste2-L236H mutation affects the thd intracellular loop of the a-factor receptor
and results in a paral block in signal transduction activity (Schandel and Jenness 1994;
Weiner et al. 1993). Previous studies (Weiner et al. 1993) showed that the affinity of ths
mutant receptor for a-factor was relatively unaffected by GTP analogs, suggesting that the
coupling between the mutat receptor and the G-protein was impaied. Anyone of thee
changes in receptor strctue could conceivably result in this coupling defect. (i)
Alterations in the a-factor binding site may obviate the energetic contrbution of agonist
binding to the alosteric transition; (ii) strctual constraints in the mutant receptor may
disfavor the conformational change; or (ii) the receptor in its active conformation may be
unable to associate productively with the G-protein. We found that abilty of a-factor to
promote the conformational transition was retained in ste2-L236H mutant receptors (Figure
5A). Thus, the signal transduction defect of ste2-L236H mutant receptors apparently
reflects a failure of the receptor to form a productive complex with G-protein in that I was
unable to detect a defect in the ligand-induced conformational change. However, I canot
rule out the possibilty that other confonnational deficiencies that were not detected in this
assay lead to the signal transduction phenotype of the ste2-L236H mutant.
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Figure 5. Effects of mutations and antagonist on the cleavage pattern. (A) Membranes from the
ste2-L236H mutant (Schandel, 1994) were prepared and analyzed as described in Figure 2. (B)
Wild-type membranes (strain 211- 3) were treated with trypsin for the period indicated in the
absence of ligand (-), in the presence of 2 11M a-factor (a), or in the presence of 2 11M
desTrpl Ala3- factor (D). Membranes were also incubated for 30 minutes in the absence of
trpsin and a-factor (lane 12).
Anta onist-induced conformations. To identify the structural features of the ligand-
occupied receptor that pert to G-protein activation, I examned effects of antagonist
desTrpl,Ala3-a-factor (Shenbagamur et al. 1983) on receptor cleavage rates. Although
ths peptide binds receptors, it is unable to trgger cell-division arest or to stimulate
induction of a-factor responsive genes (Raths et al. 1988). Figure 5B shows that
desTrpl,Ala3-a-factor differed from a-factor in its abilty to influence receptor cleavage, in
that the formation of all proteolytic fragments was slowed dramtically when the antagonist
was present. First, although both a-factor and desTrpl Ala3-a-factor inhbited appearance
of fragment F2, the antagonist showed a significantly greater effect (lanes 3, 4 and 5).
Second, antagonist decreased the rate at which fragment F3 was formed (lanes 9 and 10),
whereas a-factor accelerated the formation ofF3 (lanes 6, 8, 9 and 11). Finally, at the five
minute time point (lanes 3, 4 and 5), a weak band that migrates more slowly than fragment
Fl is apparent only in the reaction containing antagonist (lane 4), thus the cleavage that
gives rise to Fl is also apparently inhibited by antagonist. In control reactions, the
antagonist did not pertb the proteolytic activity of trpsin per se as judged by cleavage of
the chromogenic substrate BABE (not shown). These results are consistent with the thid
intracellu1ar loop playing an important role in G-protein activation since this region is
exposed to the cytosolic environment only upon agonist binding. In contrast, as both the
agonist and the antagonist inhbited the formation of fragment F2, I was unable to define a
specific role for the conformational changes that influence the C-termnal doman, except
that the reduced accessibilty afforded by the antagonist does not in itself provide a signal
that is suffcient to activate the G-protein. The distinct proteolytic pattern induced by the
antagonist implies that it promotes a conformational state of the receptor that differs from
either the agonist-occupied or the unoccupied state.
It could be argued that the cleavages that form fragment Fl or F2 are required
before trpsin can cleave the receptor in its thrd intracellular loop. If this were tre then
antagonist could reduce the rate of thid loop cleavage as an indirect consequence of its
inhibitory action at the dista cleavage sites. This does not appear to be the case since the 5
minute digestion of the a-factor-bound receptor (Figue 5B, lane 5) and the 10 minute
digestion of the antagonist -bound receptor (lane 7) are degraded equally to fragments F 
and F2; yet afer an additional 5 minutes of digestion, the a-factor-bound receptor (lane 8)
shows a greater accumulation of fragment F3 than the antagonist -bound receptor shows
after 20 additional minutes of digestion (lane 10). Hence, the reduction in rate of thid-loop
cleavage that is caused by the antagonist is apparently not an indirect consequence of
slower cleavages at distal sites in the receptor.
Discussion
In this chapter, using limited trpsin digestion of the a-factor receptor, I identified
the conformational changes that are induced by the binding of a-factor and its antagonist,
desTrpl Ala3-a-factor. a-factor caused the thid intracellu1ar loop of the receptor to
become more accessible to trpsin, and it caused a second site in the C-termnal domain
near the seventh transmembrane helix to become less accessible. Both of these
factor-induced changes were also observed with G-protein-deficient membranes; thus,
the relative rates of cleavage appear to reflect conformatiomil states of the receptor rather
than the association of the receptor with the G-protein. Previous workers have found
simar results for mamalan rhodopsin in that photoactivation accelerates proteolytic
cleavages in the thid extradiscalloop (Pellcone et al. 1985b) and inhbits cleavages in the
termnal domain (Kuhn et al. 1982). Here, it is shown that the changes in the third
intracellular loop are specific for the agonist since a-factor and its antagonist had opposing
effects on the accessibility of trpsin to this region. The importance of the thid
intracellular loop in the a-factor receptor is also apparent from the mutants that block G-
protein coupling (Weiner et al. 1993). The fact that the ste2-L236H mutant retains the
abilty to undergo the agonist-induced conformational change (Figure 5B) suggests that the
amno acid substitution in this loop blocks its abilty to associate with the G-protein.
A two-state allosteric model has been used to describe the initial action of agonists
and antagonists on the conformation of G-protein-coupled receptors (Bond et al. 1995;
Samama et al. 1993). In this model, agonists shift the dynamc equilibrium of receptor
toward the activated R * state, whereas certain antagonists, termed "inverse agonists,
stabilze the inactive R state. Only the R* state is thought to form a productive complex
with G-protein. The model makes two predictions. First, agonists and inverse agonists
should have opposing influences on the aspects of receptor conformation that are relevant
to signal transduction. Second, these conformational changes should be an inherent
property ofthe receptor (i. e., protein independent). The desTrpl,Ala3-a-factor
peptide appears to have inverse agonist activity in that a related antagonist
(desTrpl,Ala3,NleI2-a-factor) has a negative influence on G-protein-coupling (Blumer
and Thorner 1990) -- ie., GTP analogs increase the affnity ofthe receptor for antagonist
under conditions that decrease the affinity for agonist. With regard to the exposure of the
thd intracellular loop, these results satisfy both predictions of the two-state alosteric
model since a-factor and desTrpl,Ala3-a-factor have opposing influences on the rate of
thid-loop cleavage (Figue 5B), even in the absence of G-protein (Figure 4A). Hence, one
essential attbute of the R* state of the a-factor receptor may include the exposure of the
thid intracellular loop. However, the receptor can clearly exist in more than two
conformational states as the antagonist also retards the cleavage rates at two sites in the C-
termnal domain; the physiological signficance of the additional state(s) is not yet clear.
. Fluorescent modifications of the ~2 adrenergic receptor have also been used to address the
relative influences of agonists and inverse agonists on receptor conformation (Gether et al.
1995); the fluorescence emission from one or more of the modified cysteine residues
(located only in the second and thid extracellular loops) is decreased by agonists whereas
the fluorescence emission is increased by inverse agonists.
For many G-protein-coupled receptors, genetic evidence suggests that the thid
intracellular loop plays a central role in signal transduction. Constitutive mutants affecting
mamalian a2- and ~2- drenergic receptors exhibit higher affinities for agonists (but not
antagonists) even in the absence of G-protein function (Ren et al. 1993; Samama et al.
1993). Hence, the association of the third intracellular loop with the body of the receptor
may provide an energetic contribution to the relative stabilty of the R state. Certain yeast
mutants affecting the thid intracellular loop in both the a-factor receptor (Clark et al. 1994;
Stefan and Blumer 1994) and the related a-factor receptor (Boone et al. 1993) exhbit either
a parialy-constitutive signal or enhanced pheromone sensitivity. Interestingly, many of
the parially constitutive ste2 mutants also show increased affinity for a-factor (Clark et al.
1994; Stefan and Blumer 1994), consistent with the hypothesis that they reduce the
energetic requirement for the allosteric transition. Other a-factor receptor mutants fail to
undergo the allosteric transition (Chapter II or permt desTrpl Ala3-a-factor to function
as an agonist (Marsh 1992; Stefan and Blumer 1994). I believe that ths assay wil make 
possible to test diectly whether specific amno acid substitutions affect the dynamc
properties of the a-factor receptor conformation.
In addition to the thid intracellular loop, other portions of the G-protein-coupled
receptor strctue are liely to playa role in G-protein activation. The binding of receptors
to their cognate G-protein can be competed with antibodies diected against the second
intracellular loop or the C-termnal domain (Weiss et al. 1988). Similarly, bindig of the
protein to the receptor is competed by the presence of synthetic peptides that comprise a
portion of the second loop or the C-termnal domain of rhodopsin (Konig et al. 1989;
Schreiber et al. 1994). Many a-factor antagonists (Eriotou-Bargiota et al. 1992) including
desTrpl Ala3-a-factor (Appendi) appear to elicit paral activation of the G-protein, in that
they show agonist activity when the target cells are supersensitive to a-factor due to the
presence of the sst2 mutation. Since desTrpl,Ala3-a-factor does not increase the exposure
of the third intracellular loop, conformational changes at other sites in the a-factor receptor
may contribute to signal transduction. In the presence of the antagonist, activation may
result either from the reduced exposure of the C-termnal domain or from other structual
changes that were not detected by our trypsin digestion assay. However, the C-termnal
domain of the a-factor receptor is unlikely to play an essential role in G-protein activation
since truncated receptors lacking this region remain responsIve to agonist (Konopka et al.
1988; Reneke et al. 1988).
The binding of a-factor stimu1ates endocytosis of the a-factor receptor in addition
to G-protein activation (Schandel and Jenness 1994). The conformational change
necessar for endocytosis does not appear to require G-protein function (Blinder et al.
1989; Jenness and Spatrick 1986; Zanolari et aI. 1992). Endocytosis requires the
termnal domain of the receptor (Rohrer et al. 1993; Schandel and Jenness 1994) and is
not blocked by mutations il the thd intracellular loop (Schandel and Jenness 1994; Weiner
et al. 1993). It is possible that the agonist-:induced conformational changes that promote
receptor endocytosis are reflected by the reduced rates of trpsin cleavage in the C-termnal
domain. It is of mterest that these cleavages (amno acid residue 304 or 318) occur close to
the DAKSS sequence (residues 335-339) that is believed to mediate the reguation of
endocytosis (Rohrer et al. 1993). In addition to endocytosis, other a-factor responses are
mediated by the C-termal domain, including adaptation to the stimulus (Konopka et al.
1988; Reneke et al. 1988), receptor phosphorylation (Reneke et al. 1988), and changes in
cellular morphology (Konopka 1993; Konopka et al. 1988); it is conceivable that the
conformational change that we detect in the C-termal domain may also playa role in these
factor responses as well.
No high-resolution strctues for G-protein-coupled receptors are yet available.
However, for many of these receptors, models for the packing of the seven helices have
been proposed (Baldwin 1994; Strader et al. 1995). Upon ligand binding, an individual
helix may become altered in its relationship to its neighbors by undergoing a translational
piston model") or a rotational motion along its helical axs , by altering the angle at which
it traverses the membrane, or by undergoing a lateral translational motion. One possible
model for the agonist-induced conformational change in the a-factor receptor would be that
movements in helix 6 and helix 7 shield the cytoplasmic region adjacent to helix 7 (i. e.,
slower formation of fragment F2) and expose the third intracellu1ar loop, adjacent to helix 6
(i. e., accelerated formation of fragment F3). Interestingly, a mutation affecting the short
extracellular loop that connects helices 6 and 7 prevents exposure of the thd intracellular
loop upon agonist binding (Chapter 2). Consistent with this interpretation, computer-
generated simulations of the 5-hydroxy-tryptamine receptor (Luo et al. 1994; Zhang and
Tipper 1993) suggest that agonist binding causes a rotation of helix 7 that is coupled with.
rotation of helix 6, with lateral translation of helix 4, and ultimately with exposure of the
thid intracellular loop.
CHAPTER II
ISOLATION AND CHARACTERIZATION OF A MUTANT RECEPTOR
DEFECTIVE IN THE ALLOSTERIC TRANSITION
Two models account for reeptor activation by agonist: conformational induction
and conformational selection. The conformtional induction model (exemplifed by the
induced-fit model) states that bindig of agonist to the inactive state of the receptor resu1ts
in a conformational state that would otherwise be inaccessible. The conformational
selection model (exemplified by the Monod-Wyman-Changeauxmodel for alosteric
proteins) states that the receptor exists in two or more conformations even in the absence of
ligand, and agonist selectively binds and stabilizes the activated form. One view is that
neither of these mechansms are very different and that they are only extremes of the same
mechansm (Kenakn 1996).
The conformational changes associated with GPCR' s are most often interpreted in
terms of the second model. The Ternar Complex Model (TCM) is an example of such a
model because agonist binds selectively to the receptor- protein complex. Using the ~-
adrenergic receptors as an example, it was shown that GPCRs exist in high and low
affnity states and that agonist, antagonist and guanine-nucleotides influence the relative
abundance of the two states. The TCM model was recently modified (Samama et al. 1993)
to account for the properties of certain constitutively-activated receptors and is referred to as
the extended TCM. This extended TCM model has three basic tenets:
(i) The receptors in the inactive and active state are at an equilbrium even in the absence of
ligands. The conformational equilibrium constant is expressed as J; J=R/*
(ii) Kd is affected by the transition between R and R * states, and ligand binding makes a
free energy contribution to the transition ofRT In(K); K=kR/kR*
(ii) The G-protein associates only with the R* conformation.
The molecu1ar changes constitutig the switch from the R to R * form have been the
topic of much research. Furhermore, :determning the residues involved in alosteric
transition has been useful in the elucidation of the activation mechansm. To ths end,
mutations that render the reeptor constitutively active have been espeialy helpful (Scheer
and Cotecchia 1997). The constitutively active mutat receptors are thought to mic the
activated (R *) form of the receptor in the absence of the agonist. Analysis of natually
occurg receptor mutations that lead to disease have shown that in some cases the disease
was due to a constitutively-activated form of the receptor. Disruption of a salt bridge
between Lys296 in TM7 and Glul13 in TM3 in rhodopsin was found to result in retinitis
pigmentosa; mutations afectig either residue lead to constitutive activation of rhodopsin
(Robinson et al. 1992). Mutations in the TM6 such as the Asp578Gly of the Luteinizing
hormone receptor (LRH) have ben identifed in patients with famial male precocious
pubert (Shenker et al. 1993). Mutations affecting Thyroid Stimulating Hormone (TSH)
receptor have been identified in patients with thyroid adenomas (Para et al. 1993); the
resulting amno acid changes have been mapped to TM 3, 6 and 7 as well as to the third
intracellular loop. In addition to the changes in the TM regions, mutational alterations in
the extracellular loops of two different receptors (TSH and thyrotropin receptors) were
found to result in constitutive activation (Para et al. 1995) and (Nanevicz et al. 1996)
(Figure 1). Biochemical and computer simulation analysis of such mutants have led to the
suggestion that in the R form, the receptors are constrained through specific interactions in
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Figure 1. A. Artifcial activating mutations:
(l)AJrtnl rgic,(2) \illscarinic, (3) Rhodopsin, (4) Thromhin receptor.
B. Spontaneous activnting mutations: (1) LB, (2) TSH,
(3 and 4) Rhodopsin. (5) :MSH receptor. From A. Scheer, 1996,
the transmembrane regions and that binding of the agonist leads to disruption of these
constraints and to a more relaxed R * form.
Common structural features among GPCRs that are associated with different
ligands or with diferent G-protein specificities suggest the identity of amno acids that are
essential strctual determnants of receptor function. Highly-conserved residues are
therefore targets of site-diected mutagenesis. Mutation of conserved residues of the alB-
adrenergic receptor (C128 in TM3 (P rez et al. 1996) and S204 in TM5, (Strader et al.
1989)) were found to result in increased afnity for agonists as well as higher basal
signallig levels than the wild-ty control. The mutation of residues in the thd
intracellular loop have also ben found to lead to agonist-independent signalling; the
systematic mutation of the Ala293 (located in i3) of the alB-adrenergic receptor by any of
the 19 other amo acids leads to (dierent levels of) constitutive activation (Samama et al.
1992). Activating mutations in the N- and C-termnal ofthe thid loop of muscarnic
acetylcholine Hml receptors have been identified as well (Hogger et al. 1995). Moreover,
substitutions or deletions of the a-factor receptor in yeast also result in constitutive
activation (Boone et al. 1993). These results suggest that certain molecular interactions are
essential for constraining the unoccupied receptor and that interrption of these constraits
lead to agonist-independent activation.
A reciprocal approach for identifying residues involved in receptor activation is to
search for receptor mutants that are trapped in a low-affinity conformation. Mutant proteins
that are unable to attain an activated conformation are expected to show a reduced affinity
for agonist as well as diminished signallng capacity. The same phenotype would also
result from a receptor mutation that affects the ligand binding site. Nevertheless , certain
mutants of the NKI and the ~-adrenergic receptors have been proposed to cause the
stabilzation of the R form. In the NKI receptor, alanne substitution of either residue
Glu78 (in TM2) or residue Tyr205 (TM5) lead to modest reduction (26- and 38-fold
respetively) in the bindig affinity for agonists accompaned by a tota10ss of the abilty of
agonists to mediate a signal transduction response (Huang et al. 1994). These authors
conclude that both residues which are highly conserved, playa role in receptor activation
rather than in the intial binding step. Another residue conserved not only aiong receptors
that bind strctualy simiar ligands but in most GPCRs is Asp79. Therefore ths residue
is thought to be involved in maintang the agonist-bound conformation of the receptor.
The Asp79Ala substitution in the ~-adrnergic receptor leads to a 10-fold increase in Kc for
agonist in the presence and absence of G-proteins and a lO-fold increase in EC50 for
signalling (Strader et al. 1988). In the V2 vasopressin receptor, substitution of residue
Arg113 with tryptophan (fIrst extracellu1ar loop) has been found in patients with congenital
nephrogenic diabetes insipidus. Ths polar to non-polar substitution was found to resu1t in
a 20-fold increase in Kc and a 60-fold increase in EC50 (Birbaumer et al. 1994).
In ths chapter, I describe the identification and characterization of a mutation in the
yeast STE2 gene which leads to a receptor that is apparently locked in a low-affnity
allosteric state.
Materials and Methods
Isolation of Si nalln Mutant. This was done essentially as described by
Schandel& Jenness,1994. The entire STE2 coding region was mutagenized by
hydroxylamne treatment (Rose and Fink 1987) of plasmid pJBK008 (Konopka et al.
1988). The mutagenized plasmid DNA was used to transform strain 213- (MATa
ste2.1) and Ura+ transformants were replica plated to plates containing 4xl0-8 M a-factor.
The a-factor resistat isolates were chosen for fuer study. These candidates were tested
for their abilty to bind 35S- belled a-factor (5 nM) (Jenness et al. 1986). Only one
mutat (pDJ270) retaed the abilty to bind pheromone; afnity was 35% of the level
observed for wild-type cells.
To determe the location of the mutation, I subcloned four restrction fragments
(HindII-DraI, HpaI-AatII, AatII-PstI and ClaI-PstI from the mutant copy of STE2
(pDJ270) into an otherwise wild-type copy of STE2 cared on the integrating plasmid
pDJ251 (pPS3-tet STE2, URA3). Recombinant plasmids were digested with Stu and
used to transform strai 213- 3. Halo assays were performed to identify the ClaI-PstI
fragment as the region of STE2 conferrng the mutant phenotype. This fragment was
sequenced by using double-stranded plasmid DNA and the Sequenase kit from United
States Biochemicals. A single mutation (Ste2- 1274P) was found; an A to C transversion at
position 819 was predicted to result in a threonine to a proline substitution at residue 274.
A two-step gene replacement was used to replace the chromosomal copy of 
STE2 in 211-
3 with ste2- 1274P (pDJ283) creating strain 902- 1. Southern blot analysis was used to
confIrm the overall strctue of the STE2 locus.
Assa s of Res onsiveness to Pheromone. Halo assays were conducted by placing
sterile fiter discs, containing 20 III of various concentrations of a-factor on a lawn of
5x106 cells on an agar plate. The size and clarty of the halos were noted after 24 and 48 hr
at 30 oC and the diameter of the halo measured after 48 hr.
Factor-bindin measurements. Cells were cultured overnight at 30 C to a final
density of 107 cells/mI. NaN3 and KF were added to 
final concentration of 10 mM and
cells were harvested by centrifugation, rinsed twice in inhibitor medium (YM- l containing
10 mM NaN3, 10 mM KF, and 10 mMp-tosyl-L-arginine methyl ester) and the cell
concentration was determed as described previously (Jenness et al. 1983). The binding
reaction was initiated by addition of cells to a final concentration of 2x108 cells/ml with
serial dilutions of 35S-a-factor (5 Ci/mmol) in inhibitor medium in the presence and
absence of 20 cold a-factor. The amount of 35S-a-factor ranged from InM to 100
nM. After 30 min at room temperatue, a 0.09 ml of sample was diluted to 2 ml with
inhbitor medium, and the cells were collected on a presoaked ftter (Watman, GF/C).
The ftters were rinsed twice with 2 m1 of inhbitor medium for 0.4 to 0.5 mi. The ftters
were then dred and counte in liquid scintillation counter. The amount of nonspeific
binding was determed for each 35S-a-factor dilution. Specific binding was calculated as
the counts bound to ftter. The free a-factor concentration was the concentration of 
factor bound to the cells subtracted from the total a-factor concentration in the binding
reaction mixtue. Bindig data were analyzed by the method of Scatchard to fmd Kc and
Bmax (Scatchard 1948).
Competition bindig was done in a similar fashion except that the final cell
concentration for wild-ty strain was 3x108 cells/ml, final 35S- factor concentration was
2 nM, the concentration of unlabeled a-factor ranged between 2 nM to 2 JlM. For the ste2-
1274P mutant cells, the fmal cell concentration used was 5x108 cells/ml, final
35S-a-factor was 10 nM and the range of the unlabeled agonist ranged from 5 nM to 2
JlM.
The binding of 35S- factor to crude membranes was determned as well. The
reaction was stared by the addition of 400 /lg membranes in lysis buffer (1 mM
magnesium acetate , 0. 1 mM dithiothreitol, 0. 1 mM EDT A, 7.6% glycerol and 10 mM
MOPS, pH 7. , plus 1mM EDT A, 100 JlgIJlI PMSF and 100 Jlg/fll pepstatin) into tubes
containing either 10 nM 35S- factor or 10 nM 35S- factor plus 2 flM cold a-factor,
Afer incubation at 30 C for 10 min, membranes were collected on fIters that had been
dipped in 0.3% PEl, pH=7, washed twice with 2 mIlysis buffer, dred and counted in 
liquid scintilation counter. Strais assayed were 211- 3, 902- l and 213- 3, each in
trplicate.
uantitative matin eriments. Cells were grown overnight at 30 C to 107
cells/mI. 2x 106 !! cells to be tested for mating were mied with equal number of ex cells
(strai EMS63), collected on a type HA fIter (0.45-J1m pore size), and rised with 10 ml
of YM- l medium and the fIter was transferred to a YEPD plate, which was incubated for 6
h. The cells were then suspended in 2 mI of ice-cold minimal medium (without amonium
sulfate or glucose), dispersed by vortexing at high speed for 1 min, diluted and plated out
onto unsupplemented mial medium.
alactosidase assa s. Assays of ~-galactosidase activity in permeabilized cells were
performed as described by Hagen and Sprague Jr. (1984). Cu1tures were grown to
exponential phase in -tr+CAA at C, diluted to about 5xl06 cells/ml and shifted to 30
for 1.5 h. Cells were treated with a-factor for 30 minutes , and the reaction was stopped by
the addition of cyclohexide (fmal concentration, 0.02 mg/ml). Cells were collected by
centrifugation and resuspended in 0. 1 volume ofZ-buffer (10 mM KCI, ImM MgS04, 0.
M sodium phosphate, pH7). To permeabilze cells, suspensions were adjusted to 60 J1l1ml
chloroform, 28 mM ~-mercaptoethanol and 0.0075 % SDS and vortexed. The reaction
was initiated with 0.8 mg/ml of o-nitrophenyl- galactosidase and termnated after 30
min at 28 C by addition of one-third volume of 0. 1 M sodium carbonate. The A420 was
determned after clarfication by centrifugation. Units of activity were calculated by using
the formula (1000 X A420 of reaction) divided by (A6oo of cu1tue X volume of cultue
used in mI's X time of reaction in min).
Results
Mutant isolation. In order to identify residues involved in activation of a-factor
receptors, I mutagenized a plasmid-borne copy of the STE2 gene with hydroxylame and
selected mutats that exhbited a loss-of-function phenotype. Random mutagenesis was
employed since the STE2 gene product has no sequence homology with the rest of the
GPCRs and since random mutagenesis avoids bias towards any paricular residue.
Binding of a-factor to wild-type receptors induces cell division arest, therefore the librar
of plasmid-borne mutations was screened for mutations that resulted in a-factor resistance.
Fift three colonies from thee thousand transformants were identified to be resistant by
replica plating to a-factor-containing plates (40 nM of a-factor). This a-factor
concentration was sufficient to cause arest of cells expressing wild-type receptors. When
single-colony isolates were retested, three were found to display the a-factor-resistance
phenotype. The mutant plasmids were recovered from these isolates and then reintroduced
into the original ste2 deletion strain to confIrm the presence of a plasmid-borne mutation.
In principle, a mutant could show an a-factor resistance phenotype for one of several
reasons:
i) It fails to express receptors on the cell surface.
ii) The a-factor binding site is defective.
iii) a-factor binding site is intact but the receptor is unable to assume the activated
conformation.
iv)The mutant receptors are defective for G-prQtein interaction.
Only one of the mutats was found to be expressed on the plasma membranes
comparable to wild-type levels and to show 35% wild-type binding at 5 nM a-factor
concentration. Hence, this mutant expresses defective receptors on the plasma membrane.
The mutation was found to resu1t in a theonie to prolie substitution at position 274; this
residue is located near the extracellu1ar end of TM 7 (Figu 2). The localization of the
mutation rules out the possibilty that it interferes with the G-protein association of the
receptor.
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Figure 2. Localization of the ste2- T274P mutation.
Characterization of the mutant rece tor. A receptor mutant that is defective for
conformational change wil be locked into the R state and wil have a higher Kc value for
agonists. To assess the agonist affnity and cell-surface expression of the mutant, I
performed equilbrium a-factor binding assays with intat cells. Metabolic inbitors were
added to block receptor internalization. The resu1ts of the bindig experiment were plotted
according to the method of Scatchard (Scatchard 1948) (Figue 3). The Kc value for the
wild-type control cells was 3 nM and the number of sites was 4800 receptors/cell similar to
previously reported values (Jenness et al. 1986) and (Weiner et al. 1993). The mutation
was found to increase the Kc value of the receptor to roughly 60 
nM, and the results were
consistent with a nearly wild-type number of binding sites (Bmax). The amounts 
receptor protein from lysates of wild-type and mutant cells was compared by using
imunoblotting methods. Ths analysis indicated that the level of the mutant receptor
protein was roughly half the level found in wild-type cells. Fractionation of the membranes
from the mutant cells on Renografm density gradients indicated that essentially all of the
mutant receptor protein was associated with the plasma membrane (K.A. Schandel and
D. Jenness , unpublished data).
Mutant receptors that are locked in the inactive R state are predicted to show a
decreased affinity for agonists and an increased affinity for negative antagonists (inverse
agonist). The desTrpl Ala3-a-factor peptide appears to have properties similar to that of a
negative antagonist since it induces a hyperconstrained conformation of the receptor as
detected by trypsin digestion assay (Bukusoglu and Jenness 1996) and since a related
antagonist (desTrp1 Ala3.Nle12-a-factor) was shown to have a negative influence on G-
protein coupling (Blumer and Thorner 1990). Ligand binding affinities of the 
ste2-T274P
mutant cells were determned by assays that employed radioactive a-factor and varous
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Figure 3. Equilibrium binding of 35 1abeled a-factor to cells expressing wild-type 
(.)
or mutant (0) receptors. Data obtained from equilibrium binding experiments are plotted
according to the method of Scatchard and were done in mpilcalc-
concentrations of unlabeled ligand as competitor. Ths assay permts comparson of the
afnities of the mutat and wild-type receptors for agonist and antagonist. If the conditions
of this experiment are adjusted so that the concentration of radioactive ligand used and the
concentration of receptor sites are small compared with the Kd value, then the 50%
inhbitory concentration for radioactive ligand binding (IC50) wil corrspond to the Kc
value. The IC50 value obtained with the wild-type cells and unlabeled a-factor was 8 nM,
whie the IC50 value obtaed with the antagonist was 1000 nM. The IC50 value obtaned
with the ste2- 1274P mutat and unabeled a-factor was 80 nM, while a value of 800 nM
was obtaed with antagonist (Figue 4). As expected for a receptor that is in a low-affinity
form, the mutant receptors show decreased afnity for agonist whereas the affinity for the
negative antagonist is increased.
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Figure 4. Competition binding curves of cells with the wild-type (STE2p)
and the mutant receptor (ste2-T274Pp) with the agonist and antagonist.
Ligand Concentration (Molar)
The abilty of the mutat receptor to undergo the conformational change in response
to ligand was determned by using the trsin digestion assay described in Chapter 1. In
this in vitro assay, membranes containing mutant and wild-type receptors are digested
parally with trpsin in the presence of agonist or antagonist, and cleavage events are
detected by using imunoblottg methods. The concentration of ligand used in ths assay
was above Kc (2 Jl of both ligand). At this concentration of agonist, over 90% of the
receptors are expeted to be occupied whereas for the antagonist, over 65% occupancy is
expected. Membranes prepared from cells contag either the wild-ty or the ste2-
1274P mutant receptor were digested for varous periods of tie. The paral digests were
run on gels and probed with an antibody against the N-termnal portion of Ste2p, (Figue
5). As was discussed in the previous chapter, activation of the wild-type receptor by a-
factor results in the exposure of the thid loop, as a consequence, the rate at which fragment
F2 is convened to F3 is slower. Unlike the wild-type Ste2p, the mutant receptor did not
show increased exposure of the thid intracellu1ar loop upon addition of agonist (compare
lanes 4 & 5 and 7 & 8 for the mutant receptor, and lanes 10 & 11 for the wild-type
receptor). Since the mutation results in decreased affinity for agonist, it could be argued
that at the concentration used, a-factor was not bound to the mutant receptor. This issue
was addressed by performng radioactive a-factor binding experiments with the
membranes that had been prepared for the trypsin digestion assay. Addition of 2 
unlabelled a-factor was found to compete for the binding of radioactive a-factor when the
membranes had been obtained from either wild-type or ste2- 'f74P mutant cells (Figure
6). These results show that under the conditions of the digestion assay, a significant
portion of the mutant receptors bind a-factor.
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Figure 5. Trypsin digestion assay of membranes prepared from cells
containing the T274P mutation in the pheromone receptor. Lanes 1-9 are
membrane preparations containing ste2- T274P mutation, lanes 10- 12 are
membrane preparations of cells containing the wild-type STE2 receptor. -
is for no ligand , ex is for a-factor, D is for antagonist.
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Figure 6. Results of the binding experiments using membranes prepared from
cells containing the wild-type receptor or the ste2- T274P mutation.
. '
It was shown previously that antagonist binding results in a hypr-constrained form
of the wild-type receptor which is less accessible to trpsin than either unoccupied receptor
or receptors occupied with agonist (Bukusoglu and Jenness 1996). The effect of the
antagonist on the mutat receptor was analyzed by the same method (Figu 5). Whereas
the agonist apparently did not inuence the conformation of the mutat receptor, the
antagonist resu1ted in the same digestion pattern with the mutant receptor as with wild-type
(compare lanes 7 & 9 for the mutant, and lanes 10 & 12 for the wild-tye). Ths
observation provides fuer support for the arguent that the ste2- 1274P mutant receptor
can bind a-factor under the conditions of the assay (since the antagonist binds the mutant
and wild-tye receptors with similar afnity) but canot assume the activated
, "
relaxed"
conformation whereas it can assume the antagonist-induced, hyper-constrained
conformation.
To evaluate the activity of the mutant receptors in vivo I examed the dose-
response relationship for the abilty of a-factor to induce transcription of a pheromone
responsive reporter gene. Genes that respond to a-factor contain one or more copies of the
pheromone response element (PRE) upstream of the transcriptional star site (Kronstad et
al. 1987). The reporter plasmid that was used in this study is the multicopy plasmid
pJD 10 that contains a promoter with 8 tandem copies of PRE fused to the coding sequence
for the coli galactosidase (Hasson et al. 1994). Since this assay measured short-term
responses to a-factor, it avoided the complications resulting from long-term assays (i.
desensitization). Cells were incubated at 30 C for an hour after addition of various
concentrations of a-factor. The ste2- T274P mutant receptor was found to signal up to
wild-type levels at high a-factor concentrations (Figure 7). The EC50 in this assay is the
factor concentration that gives 50% of maximal signalling. The EC50 value for the wild-
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Figure 7. Transcriptional induction assay. Open squares represent
wild-type , closed diamonds represent the ste2-T274P mutant
receptors. Data shown are the mean values:! SEM.
type control cells was 0.3 nM whereas the EC50 for the 
ste2- T274P mutant was 10 nM.
Ths result indicates that whereas the ste2-T274P resu1ts in a lO-
fold decrease in agonist
afmity, it causes a 33-fold difference in the dose-response.
As a second measure of mutat receptor activity in vivo, K. Schandel assayed the
abilty of the ste2- T274P mutant to undergo ligand-induced endocytosis of cell-surace
receptors. The assay was performed as described (Schandel and Jenness 1994) except that
500 nM a-factor was used for the mutant cells (as opposed to 10 nM for the wild-type
cells) to account for the Kd defect of the mutant receptor. It was observed that 
at ths
concentration of agonist, the mutant receptor was endocytosed 
alost as rapidly as the
wild-type receptors (Figue 8). At 10 nM, endocytosis of mutant receptors was
undetectable (not shown). These results are in agreement with the transcriptional induction
experiments (Figue 7), in that the mutant receptors are active in both assays but 
requie
higher a-factor concentrations to achieve a comparable effect.
In order to determe whether the ste2- 1274P mutation is domiant or recessive, I
performed a-factor halo assays that monitor the abilty of the pheromone to arest the
division of cells on an agar surface. In this assay, fiter disks 
containing different
quantities of a-factor were placed on a petri plate that had been seeded with cells of the test
strain. After 1-2 days, the abilty of cells to grow In the area surrounding the disk was
evaluated by measuring the diameter of the inhibitory zone ("halo ) and by evaluating the
clarty of the zone. When a single-copy plasmid encoding the 
ste2- 1274P mutant receptor
(pDJ283) was used to transform the 
ste2 deletion strain , I found that the resulting
transformants gave halos that were smaller and more turbid than the clear halos obtained
with the wild-type control strain (Figure 9A). Turbidity in the halo assay (which measures
STE2
t=-
t=8
t=20
.. 20
fraction number
Ste2-T274P
-- 
t =-
t=8
t=20
fract ion number
Figure 8. Endocytosis of wild-type STE2 and Ste2- T274P receptor.
Renografin gradients of 1 min before, 8 min and 20 min after addition
of a-factor are plotted. 10 nM and 500 nM of agonist was used respectively.
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Figure 9A. Dominance assay. Halo assays were done with cells containing
either a chromosomal copy (STE2) or a deletion (ste2L1) of the wild-type receptor
expressing different STE2 alleles from a single-copy plasmid. The clarity of the
halos are indicated. Strains used are 211- (STE2) and 213- 3 (ste2fl)
transformed with pJBK008 (STE2), pDJ253 (ste2-L236H) and pDJ282
(ste2- T274P). Filter disks contain 50 , 25 , 12.5 or 6.25 11M of a-factor.
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In the plot above, each sign represents the following: closed circles
STE+/STE2+, closed squares ste2-/STE2+ , open squares
STE+/ste2L236H, closed triangles STE+/ste2-T274P, open circles
ste2-/ste2-L236H and pluses ste2-/ste2-T274P.
long-term response to pheromone) indicates either reduced signalg abilty and/or
increased recovery rate of the mutant receptor. The same plasmid containing the 
ste2-
1274P, introduced into a STE2+ strain resulted in turbid halos that were larger than the
ste2- 1274P mutant plasmid in the ste2 deletion strain but not as large as the the halos
produced by wild-tye cells. Ths intermedate phenotype indicates that the ste2- 1274P 
semi-dominant. In comparson ste2-L236H mutation was shown to be recessive since
plasmids containg ths alele resulted in wild-type halos when introduced into a STE2+
strai. Ths phenotype could be due to receptor oligomeriation (btween wild-ty and
mutat receptors) or to the sequestration of cellu1ar components such as G-proteins by the
weak-signalling ste2-1274P mutant receptors.
The halo assays were also repeated with high-copy plasmids containing the mutant
and the wild-type receptors by A. Yesilaltay. When the wild- type STE2+ was contained on
a multi-copy plasmid, the halo size was the same as that obtained with a single-copy of
STE2+ (Konopka et al. 1988), (Figure 9b). Interestingly, the multi-copy plasmid
containing the ste2- 1274P resulted in halos that were larger than those observed for the
single-copy plasmid that contained the ste2- 1274P but was stil turbid and smaller than
wild-type STE2 on a single-copy plasmid (Figure 9B). Increasing the number of the wild-
type receptors did not enhance signallng (presumably the G-proteins are limiting), whereas
overexpressing the mutant receptors led to bigger (but stil turbid) halos (Figure 9B). Ths
is the expected result of a receptor with low-affInity binding since increase in the receptor
numbers of such a receptor would result in a stronger signal (by increasing the number of
receptors bound to ligand). It is also possible that the ste2- T274P mutation leads to a
decrease in the absolute number of receptors such that even in the cells that are
overexpressing the ste2- 1274P, the mutant receptor concentration in the cell is limiting.
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Figure 9B. Halo assay plots of cells lacking chromosomal receptor but
expressing the wild-type receptor or the Ste2- T27 4Pp from either a single
copy (YCp) or a multicopy (YEp) plasmid.
Discussion
In order to dissect regions of the receptor that ar involved in allosteric transition of
the yeast pheromone receptor, I sought a receptor mutant that was defective for this
transition. Such a receptor mutant wou1d be expected to have a lowerafftnty for a-factor
and decreased signallig capacity. A single mutation was identified that fulfiled the above
criteria; it resulted in the substitution of a Th to a Pro at residue 274. When a receptor
mutant exhbits a decrease in the afnity for the agonist as does the ste2-1274P it is
diffcult to discern whether this is due to an alteration in the ligand bindig site or in
allosteric transition (Figue 10). The diffculty in differentiating between these two
phenomena is due to the fact that the isomerization constant canot be measured diectly for
GPCRs. The issue can be addressed, however, by comparng the apparent binding
affinity, and the basal and induced levels of signalling for the wild-type and the mutant
receptors. I wil discuss the results in terms of those that substantiate the 274th residue
role in either binding the ligand or mediating allosteric change.
The ste2- 1274P mutation results in a decrease in the affinity of the receptor for a-
factor, and an increase in the affinity ofthe receptor for the antagonistdesTrp1 Ala3-a-
factor. This is the expected phenotype of a receptor that is locked in a low-affinity form.
As discussed in Chapter I, the desTrpl Ala3-a-factor is thought to be an inverse agonist
since a related antagonist (desTrp1 Ala3 Nle12-a-factor) has a negative influence on G-
protein-coupling (Blumer and Thorner 1990) and since it induces a hyper-constrained
conformation of the receptor (Bukusoglu and Jenness . 1996). Inverse agonists show
preferential binding to the low-affnity form of receptors (Bond et al. 1995); computer
FigurelO. Allosteric transition model showing: a. equilibrium of the 2
states of the wild-type receptor, b. receptors with a simple-binding site
mutation, c. a mutation affecting the affinity of one state of a receptor
d. a mutation altering the equilibrium in favor of the inactive (R) form.
aided simulations of the ~2-adrenergic receptors predicted that an increase in the
isomerization constat (R *) would result in an increase in the afInty for negative
antagonists and decrease in the affInty for agonists (Samama et al. 1994).
In addition to the Kd defect, the ste2- n74P mutation reduces the abilty of the
receptor to undergo the agonist-induced conformational change. Neverteless, the mutant
receptors are able to undergo the antagonist-induced change. These resu1ts are consistent
with the idea that Th274 is involved in the agonist-induced activation of the receptor and
that its substitution leads to a receptor that is locked in a low-afInty conformation.
The transcriptional induction assay showed that the mutant receptor can signal up to
wild-type levels although its signalling abilty was impaied 33-fold. The decrease in the
signaling abilty is more than could be accounted for by the decrease in the Kc which
suggests that the ste2- 1274P mutation affects allosteric transition. Even if the change in
Kc and the change in signalling abilty of the mutant receptor were exactly the same, this
would stil not be inconsistent with the ste2- 1274P mutation changing the allosteric
equilbrium according to the theoretical calculations of the two-state model.
Initially, it seems surprising that a mutant that is defective for allosteric transition
can achieve maximal signalling levels when more agonist is added. Upon analysis of the
data, it can be seen that although the Kc of the wild-type STE2p is about 3-8 nM, the EC50
is detennined to be 0.3 nM from the transcriptional induction assay; this suggests that at
most 10% of the receptors need to be occupied to result in 50% maximal signalling.
Unless the ste2- 1274P mutation leads to less than 10% receptor occupancy by the agonist
the mutant receptor would be expected to achieve wild type levels of signalling in the
transcriptional induction assay. The halo-assay results also suggest that, even at 
very high
factor concentration the mutat receptor responds differently than the wild-ty receptor;
halos with mutant receptor ar smaller and tubid, suggesting that either the signal
generated by the mutant receptor is weaker and/or is desensitized quicker. This argues for
;!: .!
the idea that the signal generated from the mutat receptor is qualtatively and quantitatively
different than wild-type.
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Another conclusion of the transcriptional induction assay resu1ts is that the 
mutat
receptor must be able to assume the R* conformation to some extent (since it can signal);
1-, ,
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ths is in disagreement with the trsin assay. One explanation for this discrepancy could
be the limitation of the trsin assay which can detect only the change regardig the thd
loop related to activation. It is highly likely that there are other changes associated with the
R * form, e.g., the exposure of the second intracellular loop and the changes associated
:;;1
with the C-termnal tail, which the ste2- 'n74P might not be impaied for. Another I;;'
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argument could be the difference between the 
in vivo and the in vitro assay; it cou1d be that
the allosteric equilibrium (R*/R) is smaller 
in vitro than in vivo. In other words, the factor
that stabilzes the R * form of the receptor 
in vivo is lacking from the membrane
preparations used in the trysin digestion assay. The presence of a putative protein that
stabilzes the R* form could be addressed by looking for suppressors 
ofthe ste2-1274P
that would enable it to mate like wild-type.
A direct way of differentiating between the affect of 
ste2- T274P on the binding site
versus the conformational change would be to look at the basal levels of signalling with the
mutant receptor. If ste2- T274P is indeed a simple binding-site mutant
, the basal levels
would be expected to be the same as wild-type receptor. If, on the other hand, the mutation
changes the equilbrium between the two states of the receptors in favor of the inactive
form, it should decrease the basal level of signaling. 
Unfortately, ths expetation
canot be teste ditly since, in yeast cells, post-receptor steps ar responsible for
majority of the basal signal or "noise" (Hasson et al. 1994). Isolatig suppressors of the
ste2-T274P mutation would help resolve ths issue; the effect of the ste2- T274P on basal
levels could then be determned indiectly by comparng the basal levels of the suppressed
and the unsuppressed ste2- T274P mutat.
CHAPTER III
SUPPRESSORS OF ste2- T274P
It appears that the substitution of proline for threonine at position 274 of the
pheromone receptor afects the allosteric transition. In priciple, the alosteric transition
could be altered by either of two mechansms: by alterig the relative free energy of the R
and R* states or by alterig the relative affinity of the R and R* states for agonist.
Accordingly, the propertes of the ste2- 1274P mutant receptors reflect increased free
energy of the R * form or decreased free energy of the R form; alternatively, the ligand
binding site may have been altered so as to reduce the relative affInity of agonist for the R*
form of the receptor. Any of these outcomes wou1d lead to reduction in the afnity of the
receptor for agonist, without reducing its affinity for antagonist.
A suppressor search was initiated to resolve the mechansm by which the
ste2- 1274P blocks conformational change as well as to identify residues on the receptor or
other proteins that contrbute to the allosteric transition. Suppressors that reverse the
trypsin digestion pattern and the Kc phenotype would strengthen the hypothesis that the
ste2- 1274P is locked in the R state. The possibilty that other proteins affect
conformational change of Ste2p is suggested by the following:
1. It is known that ste4 deletion alters the Kc of the receptor for a-factor which suggests
that at least G~ affects the conformation of the receptor (Jenness et al. 1987).
2. My prelimnar results suggest that SST2p affects the conformation of the receptor
(Appendix).
3. Most significantly, in the in vitro 
proteolysis assay, the ste2- 1274P does not undergo
the conformational change but it signals 
in vivo as determned by the ~-galactosidase assay.
This suggests that a factor present in whole cells stabilzes 
the ste2- T274P receptors in the
activated state and that this factor is absent in the membrane preparations used for the
trpsin assays.
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Materials and Methods
,,'
Isolation and characterization of su ressor mutants. Haploid cells of strain
1',
910- 1-4 ( MATa 381 G ste2 :LEU2 ade2 ADE6 leu2 ura3 TYRl) containing the
ste2- T274P allele on a plasmid (pDJ270; CEN, URA3) were mutagenized by ethylmethane
sulfonate (Prakash and Sherman, 1973) to about 70% survival. Mutagenized cells from
each of the twelve independent pools were cultued overnight to a density of 4 x 106 cells
per ml in minima media lackig uracil (with casamno acids). 107 mutagenized a cells
were challenged to mate with 107 a-cells (strain 913- 4; MATa 381G ste2 ::LEU2 ADE2
Ij'
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1"1ade6 cyh2 r leu2 ura3 TYl) and collected on a type HA fiter, the fiter was transferred to
a YEPD plate. Afer a 6 hr incubation at 30 oC, the fiters were transferred to selective
ri.
1'';
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liquid medium (minimal medium supplemented with lysine, trptophan, histidie and
casamno acids) and allowed to grow overnght at the same temperatue. The resulting
diploid cells were subcultued in selective liquid medium to enrch further for diploid cells.
The population enrched for diploids was induced to sporulate and random spores were
spread on YEPD plates with 10 Ilg/ml cycloheximide plates (with no additional adenine).
Mating type of the red, cycloheximide resistant haploid cells 
(ade2 ADE6 cyh2 ) was
determned by using the cross-stamp mating test; fertile spores of the a mating type were
selected which showed the presence of a suppressor m).tation. Forty-three MATa isolates
were first tested for the presence and for the specificity of extragenic suppressors. Isolates
that had been cured of the plasmid (leaving chromosomal 
ste2.1 as the only STE2 allele)
were retested for mating to rule out by-pass suppression. The allele-specificity of each
suppressor was tested by introducing the vector (pJBK007), the 
STE2 plasmid
(pJBK008), the ste2-L236H mutant plasmid (pDJ253), the ste2- T274P plasmid (pDJ270)
If'"
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Iiiand then repeatig the cross-stamp mating test. The ste2-L236H mutant receptors are
proficient for the agonist-induced conformational change (see Chapter I). Ofthe five
extragenic suppressors that reproduced the fertlity phenotye, none were found to be
specific for the ste2- T274P; they allowed both receptor mutants as well as the wild-type
STE2 to signal better as determned by halo assays. Therefore, they were not considered to
be relevant to the conformational change of the receptor.
Linkage of the suppressor mutations to the plasmid (i.e., intragenic suppressors)
was determned by extractig the plasmid from yeast cells, propagating it in E.coli and
retransformng the original MATa ste2.1 
strain (910- 4). For the fort-two isolates that
were found to be fertile, five of the suppressor mutations were found to be lined to the
EMS mutagenized plasmid for fertilty, indicating that the suppressing mutation was in the
receptor itself. These intragenic suppressor mutations were sequenced and then recreated
either by subcloning or site-directed mutagenesis both as single mutations and in
combination with the initial ste2- 1274P mutation and were integrated into the chromosome
for further analysis.
Cross-stam matin test. Strains to be tested were patched onto YEPD master plate
and cross-stamped with an inoculum oftester strains PTl 
(MATa hom3 ilvl canl) and PT2
(MATa hom3 ilvl canl) perpendicular to the patches. The plates were incubated overnight
at 30 C and then replica plated onto a minimal plate to select for diploids. Fertile MATa
strains produced prototrophic diploids when crossed with PTl, fertile 
MATa strains
produced prototrophic diploids when crossed with PT2, and sterile strains failed to produce
prototrophi diploids with PTI or PT2.
Int the su ressor mutations onto the chromosome. To determine the
location of the suppressor mutations in the 
STE2 gene, the mutagenized plasmids (pDJ349
352) were purfied, propagated in 
coli and sequenced by using the double-stranded
fi:
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sequencing method (Sequenase kit from United States Biochemicals). A single mutation
was found in each mutat: G to A transition at positions 448, 684, 791 and 884 which lead
to glycine to asparic acid substitution at position 163 for the fIrst and alane to theonie
substitution at positions 229, 265 and 295 for the rest. The fIrst two mutations which were
cared on restrction fragments AatI-DraI (for G163D) and AatI-ClaI (for A229T), were
subcloned into an integrating vector caring either a wild-type copy of STE2 (pDJ251;
URA3) or the ste2- T274P (pDJ283; URA3). The other two mutations (A265T and
A295T) could not be separated from the T274P mutation due to their proxity to the
original mutation; therefore the ClaI-Pst! fragment containing both the suppressor mutation
and the original T274P mutation were subcloned into pDJ283; in order to create them
individually, site-directed mutagenesis was employed. The subcloned plasmids were
linearized with Pst! in order to direct integration at the 
STE2 locus and were tranformed
into strain 1378- (MATa 381G leu2 ura3 barl ste2- TIOO); strain 1378- l was created
by transformng 211- 3 with the Pst! linearzed pDJ276 (pPS3, 
tetR, ste2-SspA, URA3,
K. Schandel; unpublished work) and selecting FOAR colonies that were sterile. This strain
contains a deletion of the STE2 coding sequence; therefore it is a non-mater; therefore
integrants were selected by picking FOA resistant isolates (indicates a ura- phenotype) that
were fertile.
Site-directed mutaeenesis. The suppressor mutations ste2-A265T and ste2-A295T
cou1d not be separated from the original ste2- 1274P mutation by subcloning because ofthe
lack of unique restrction enzyme sites in ths region. Therefore, they were recreated in the
STE2 gene by using site-directed mutagenesis; Muta-gene M13 in vitro Mutagenesis Kit,
version 2 , BioRad, Richmond, CA 94804. For this purose, STE2 was cloned into the RF
form of phage M13mpl8 and the resulting recombinant phage was propagated in E. coli
dut, ung strai (CJ236). Phage parcles whose single-stranded DNA contais uracil in
thymie positions are produced in ths strain. The uracil containg DNA was purfied and
used as template in the in vitro mutagenesis reaction. Ths was then transformed into a
strain with a functional uracil N-glycosylase, thus selecting against the parent strand.
Single-stranded DNA from the resulting phage paricles were sequenced in the Nucleic
Acid Facilty. The priers used for the in vitro mutagenesis were
CGAT AAT ATTCATCcrCACAT ACAGTIGAACC3' and
CA TCAA TGTGGACCACGGCTGCT AAT AA TG3' , respectively (from Genemed
Biotechnologies, South San Francisco, CA).
Other assays such as determnation of IC50, ~-galactosidase assays, trpsin
digestion assay and quantitative matings were performed as described in the Materials and
Methods section of Chapter m.
Results
In order to identify factors that affect receptor conformation, I sought suppressors of the
loss-of-function alleles of ste2- T274P. A mutant isolation scheme was designed so as to
allow the detection of both extragenic and intragenic suppressors (Figure 1). EMS
mutagenesis was employed to randomly mutate the ste2 deletion strain that cared the
910- 4/ YCp Ste2-T274P (mates poorly)
EMS mutagenesis
mate with 913-
sporulate diploids
plate random spores
(improved mating)
perform cross-stamp mating test on haploid segregants
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43 fertile MA Ta isolates
cu str of PlaSmid
42 plasmid-dependent isolates
transform with vector, STE2, 
ste2-L236H.. ste2-1274 .
none of the 5 extragenic suppressors
were specific for Ste2-T274P
extract and purify plasmid
transform 910-
5 mutants specifc for suppression
of ste2-T274P
Figure 1. Isolation scheme for the suppressors of 
ste2- T274P the mutant receptor.
ste2- 'n74P allele on a single-copy plasmid. Suppressors that reversed the poor-matig
phenotype of the parent strain were selected by challenging separate mutagenized pools of
the MATa parent cells to mate with MATa cells that contained the 
ste2L1. Diploid cells
were selected and then induced to sporulate. Random spores were spread on YEPD plates
containg cyclohexide and allowed to germnate. To ensure that the haploids were a
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resu1t of a cross between the two parent strains , I selected red, cycloheximide resistant
colonies (ade2 ADE6 cyh2
). 
These isolates were transferred to plates lacking uracil to
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select for strains that contaed the plasmid. The mating type and fertlity of the suriving
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isolates were determned by using the cross-stamp mating test. Isolates that had been cured
of the plasmid were retested for mating to rule out by-pass suppression. The presence and
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the specificity of the extragenic suppressors was tested fIrst. Of the fort-two fertile
isolates, five contained suppressor mutations that were linked to the plasmid, and the rest
f' 
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of the suppressors were chromosomal. None of the extragenic (i.e., chromosomal)
suppressor strains were found to be allele-specific as they exhibited enhanced mating
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(determned by cross-stamp test) and a-factor sensitivity (halo-assays) when transformed
with plasmids containing three of the alleles of STE2 tested (ste2- 'n74P, ste2- L236H
STE2). I conclude that the mutated gene products resu1ting in suppression must be
involved in one or more general aspect of pheromone response such as desensitization or
post -receptor events in the pheromone response pathway.
Two criteria were used to confIrm the presence of intragenic suppressor mutations.
First, no suppression was observed when the mutant was cured of the 
ste2- 1274P plasmid
and retransformed with a second unmutagenized copy of the same plasmid. Second , when
the plasmid was extracted from the mutant and used to transform an unmutagenized 
ste2
deletion strain, the resulting transformant exhibited the suppressed phenotype.
Suppression was evaluated by testing for the reversal of the 
ste2- 1274P mating defect and
for a-factor responsiveness as judged by halo-assays. Five intragenic suppressors were
found to fulfill both criteria (pDJ 348 through 352). The position of the suppressor
mutations were determned by subc10ning and DNA sequencing. Of the five suppressor
mutants , two were found to contain the identical mutation, therefore further work was
I'"
(11limited to the four suppressor mutations (pDJ 349 though 352), The suppressor mutations
were separated from ste2- T274P 
either by subc10ning or by using site-diected
mutagenesis. Thus, I created plasmids contaning each suppressor mutation alone and in
combination with the intial ste2- T274P 
mutation. These single and double mutant alleles
were introduced into the chromosome at the 
STE2 locus in an otherwise normal genetic
context for subsequent analysis. These strains are isogenic to strain 211- 3 except at the
ste210cus they contain ste2-G163D- 1274P (1379- l), ste2-G163D (1380- l),
ste2-A229T(1381- l), ste2-A229T- T274P (1382- l), ste2-A265T (1389- l),
ste2-A265T- T274P (1390- l), ste2-A295T (1391- l), ste2-A295T- T274P (1392- l).
Localization and ma of su ressors. All four suppressors affected amino
acids near the ends of transmembrane helices (Figure 2). They resulted in the substitution
of glycine to asparic acid at residue 163 (ste2-G163D), and alanne to threonine
substitutions at residues 229 (ste2-A229T), 265 (ste2-A265T) and 295 (ste2-A295T). The
ste2-A265Tmutation is predicted to affect the extracellular end of the sixth transmembrane
helix; hence, it potentially affects the binding site. Its functional assignment is therefore
subject to the same ambiguity as the ste2- T274P with respect to its direct effects on a-
factor binding or to its effects on overall conformation. In contrast, the other three
mutations affect amno acids at the junction of the transmembrane helices and the
intracellular loops; these regions are unlikely to play direct roles in binding of a-factor.
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Figure 2. Amino acid substitutions associated with the suppressor mutations in
the ste2 gene.
uantitati matin assa s. The suppressors of ste2- T274P were originally identified
as causing reversal of the mating defect in a qualtative mating assay (cross-stap matig
assay). To obtain a quantitative assessment of the suppression phenotype, I performed
fiter mating assays with the suppressor mutants containing ste2- 1274P and with
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suppressor mutants in an otherwise 
STE2+genetic background (Table I). Whereas the
ste2- T274P mutant showed a severe matig defect (5% ofthe wild-type activity), mating
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activity was reversed to essentialy normal levels by all four suppressor mutations (52-
100% of the wild-type activity). Small reductions in mating activity as compared to wild-
.-. ,..
Ii .
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type were observed upon the introduction of the 
ste2-G163D, ste2-A265T and ste2-A295T
aleles into the otherwise wild-type background (44-58% ofthe wild-type activity).
!t.:t.
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factor affnity. The original ste2- 1274P mutation results in a lower affinity for the
agonist compared to the wild-type receptor (IC50 of 80 nM as compared to 8nM, Chapter
::,
;iA
~~~
.1 'f
II. In order to determne whether the suppressor mutations correct the a-
factor binding
j.'
t:(;'
defect in the ste2- T274P mutant receptors, I examned the a-factor binding properties of
I;.'
11.
the ste2- 1274P mutant strains containing the various suppressor mutations. To determne
whether the suppressor mutations affect the affinity of the 
ste2-1274P I also examned the
binding properties of the suppressor mutations in the absence of the 
ste2- T274P mutation.
factor affnity was determned by examning the abilty of cold a-factor to compete with
the radioactive a-factor for binding to the varous mutant strains. The IC50 value is the
concentration of the cold a-factor that inhbits binding of 50% of radioactive a-factor. The
assay conditions were such that the receptor concentration and the amount of the
radiolabeled-agonist (L) were below Kc. Under these conditions , the IC50 approximates
the equilbrium dissociation constant Ki,since;
Ki= IC50 / ( 1 + L /Kc) (Siegel et al. 1989)
Strain Quantitative IC50matin
g (
STE2 100
Ste2- T274P
'J,,)
Ste2-A229T 100
"J'
Ste2-A229T-T274P 100
Ste2-A265T
Ste2-A265T - T27 4P
Ste2-A295T
Ste2-A295T-T274P 150
Ste2-G 163D
Ste2-G 163D- T27 4P
j;I:
I:.
Table I. Results of the quantitative mating and competition binding experiments with cells
containing the wild-type receptor, the ste2- T274P 
and the suppressor in combination with
the ste2- T274P mutation or in an otherwise wild-type genetic background. Quantitative
matings are expressed as % of wild-type. Strains used are 211-
(STE2), 1379-
(ste2-G163D, T274P), 1380- l (ste2-G163D), 1381-
(ste2-A2291), 1382-
(ste2-A229T, T274P), 1389- (ste2-A2651), 1390-
(ste2-A265T,T274P), 1391-
(ste2-A2951), 1392- (ste2-A295T, T274P) and 902-
(ste2-T274P).
The resu1ts of the binding experiment are tabulated in Table I. If the decreased
afnity of the ste2- T274P mutant is a consequence of its inabilty to undergo the 
alosteric
transition, then the suppressor mutations that affect allostery would be predicted to increase
the receptor s affinity to agonist. As expected, the three suppressors brought IC50 to near
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wild-type levels, and the ste2-G163D, T274P mutant gave an intermediate value of 50 nM. I:'
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Levels of rece tor rotein in the su
ressor mutants. An important
consideration in the analysis of any mutat protein is the level of protein accumulation. The
;. ,
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effect of the suppressor mutations on the expression levels of the receptors was 
determned
" . ;'
by performng Western blotting analysis on crude lysates that had been prepared from the
mutant strains. The total Ste2p levels of two of the suppressors 
(ste2-A229T and
. .' :" :
ste2-A295T) were found to be considerably lower than the wild-type levels (Figue 3). ii.
Ths could be due to either increased rates of degradation or decreased rates of synthesis.
In contrast, the total Ste2p levels of the 
ste2-A265T mutant and the ste2-A265T, 1274P
j:;
double mutant were higher than the 
STE2+ control. This could be due to a feedback
:/'\ .
mechansm of the mating pathway since pheromone response (and presumably signaling)
results in an increased accumulation of 
STE2 mRA (Harig et al. 1986).
hi..
Basal levels of nalln in the su ressor mutants. If the suppressor mutants
affect the conformational state of the receptor, they would also be expected to increase the
basal level of signallng (Le., in the absence of agonist). This issue was addressed by
determning the expression levels of 
galactosidase in cells containing the 
ZacZ gene fused
to an a-factor inducible promoter. Strains containing the suppressors
, both alone and in
combination with ste2- 1274P were examned. The assay was performed by using cells
that had received either no a-factor or IJlM of a-factor for an hour (Table II). Except for
Genotype: STE2 ste2A229T ste2A229T.TPste2G163D ste2G163D.TP stc:2A265T
protein: 5 10 10 10 10 10 
(Ste2p): O.3x
1.3x
Geotype:
!- protein:
STE2 ste2A265T TP ste2A295T ste2A295TTP ste2T274P10 10 10 10 
(Ste2p J: 2Sx 75x
Figure 3. Amounts of receptor protein in the 
ste2 mutants. Cleared celllysates were
resolved by using anti- termnal Ste2p and immunoblotting methods. 
The relevant
genotypes and the total amount analyzed are indicated. The relative concentration of
receptor protein in the cell was estimated from densitometric analysis of the
immunoblot and normalized to wild-type value. Strains used are 211-
(STE2),
1379- (ste2-G163D, T274P), 1380- l (ste2- G163D), 1381-
(ste2-A2291), 1382- (ste2-A229T, T274P), 1389- (ste2-A2651), 1390-
(ste2-A265T, T274P), 1391- (ste2-A2951), 1392- (ste2-A295T T274P) 
and
902- (ste2-T274P).
. . . .
strain
no a onist M a-factor
meanSD median meanSD median
STE2
246 246
Ste2-T274P
194 162
Ste2-A229T-T274P 35:t4
188 185
!1;I'jltlll
Ste2-A265T-T274P
217:18 217
Ste2-A295T-T274P
253 253
;ll
t;'\1
Ste2-G163D-T274P
222 182 , :P:;
Ste2-A229T
237 286
- '
;':L
. !
Ste2-A265T
259 163 243
:'1
! ' 
Ste2-A295T
216 238
-, 
Ste2-G163D
176 176
The significance of the differences between the basal levels for the
different strains were determined by the paired student t-
test:
STE2 and ste2-A229T
STE2 and ste2-A265T
ste2- T274P and ste2-A229T, T274P
ste2- T274P and ste2-A229T
ste2-A229T and ste2-A229T, T274P
p=0.015, different at the 0.05 level
p=0.03, different at the 0.05 level
p=0.018, different at the 0.05 level
p=0.00157, different
p=0.015
., "
Table n. Results of 
galactosidase assays with and without agonist (basal). 
MeanSD
for each strain is given. Induced levels of the 
suppressors in the T274P background were
not significantly different from those in the wild-type background except for the
Ste2-A229T-T274Pp. Strains used are 211-
(STE2), 1379- (ste2-
G163D, T274P), 1380- l (ste2- G163D), 1381-
(ste2-A2291), 1382- (ste2-A229T, T274P), 
1389- (ste2-A2651), 1390-
(ste2-A265T, T274P), 1391- (ste2-A2951), 
1392- (ste2-A295T, T274P) and 902-
(ste2-T274P).
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the ste2-G163D mutant, the suppressor mutants had significantly higher basal levels than
the wild-type control strain (as determned by the paied student t-
test). In the suppressed
ste2- n74P mutants, the basal levels were not significantly different than the wild-type
STE2. This is consistent with the idea that the 
ste2- T274P mutation leads to constraints in
I :.it : :\ i::
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the receptor that favors the inactive state (low-affinity), and that these suppressor mutations
reverse this constraint and result in a receptor that is activated more easily. The e' ili: 
ste2-G163D mutant had low basal activity both in the absence and the presence of the
ste2- n74P mutation.
. ." '
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The maxmal levels of signalling (i.e., in the presence of a-
factor) for the
ste2-A265T and A295Tmutants, both alone and in combination with 
ste2- 1274P,. were
l" j:
" '\; ' : . , 
comparabl to the values obtained with wild-
type cells. In contrast, the 
ste2-G163D,. the
ste2-G163D, n74P and the ste2-A229T, n74P 
mutants showed lower signalling capacity
compared to the wild-type control. A decreased signaling capacity could either be due 
the diect negative effect of the mutations on signalling or due to the negative effect that
(",
these mutations have on the accumu1ation of receptor protein.
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Arrest of cell division. a-factor causes a cells to 
arest division in G 1. Since the
suppressor mutations resulted in increased basal transcription of a-
factor inducible genes,
they may also lead to slower progress of the cell division cycle. To address this issue, I
introduced the plasmid containing the strongest suppressor mutation 
ste2-A229T (pDJ355)
into a strain which contained a temperatue-sensiti
allele of STE5 t strain 751- 11-
(MATa ste5-3 ste2- 10::LEU2) 1. The STE5 gene product is required for a post-receptor
step in the pheromone response pathway; hence it should block cell-cycle 
arest when the
receptor is constitutively activated (Figure 4). Plates containing the transformants that had
been cultured at 34 C were replica-plated; the replicas were incubated at 22
C and at 34
Activated Receptor
STE20
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Figure 4. The constitutivity assay. Mutations leading to constitutively
active receptors will grow at 34 C but not at 22 C; at the restrictive
temperature there will not be any stable 
STE5 gene product that could
signal cell arrest.
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If the mutant receptors infuence the cell cycle, 
then the cells would show growth defects
only at the restrctive temperatue due to continuous signalling. At both temperatues
suppressor mutants grew at comparable rates to the wild-
type control, indicating there was
no strong influence of the mutant receptor on cell-cycle. These results suggest that the
increase in basal activity observed with the suppressor mutations is not strong enough to
provid a sustained block for cell-cycle progressio
Res onsiveness to artial a onists. Increased basal signallng suggests that 
the
receptors containig the suppressor mutations are in a more readily activatable state than the
wild-type receptor. In ths case, it is reasonable to expect that they would respond better to
parial agonists. This possibilty was tested by 
performng halo assays with the suppressor
mutants ste2-A229T, ste2-A265T and ste2-
A295T strains 1381- l, 1389- l and 1391-
1 respectively. The paral agonists tested were the a-
factor from the related yeast
kluyveri and the AN-37 and AN-44 analogs of a-
factor prepared by Cadus
pharaceuticals. AN-37 contains multiple amno acid substitutions in the N-
termnal one-
third of the a-factor molecule whereas AN-4 and 
kluyveri factor contain
substitutions in the middle one-third of the a-
factor (Table il). AN-37 and AN-44 bind
wild-type receptors with Kd values of 3xlO-
7 and 2xlO-5 M respectively (M. Cui and D.
D. Jenness, unpublished). Both were diluted in dimethyl formamde (DMF); DMF alone
does not result in halos as shown in Figure 5. The concentration used was 5xlO-
7M for
AN-37, 5xlO-5 M for AN-4, and 2xlO-
4 M for kluyveri factor. As seen in Figure
, both the ste2-A229T and ste2-A295T 
mutants produced larger halos with kluyveri
factor and AN-44 as well as with a-factor than the wild-
type receptor; the 
ste2-A229T
mutant was also found to produce larger halos with AN - 
37. The ste2 -A265T mutant
produced turbid halos with every agonist tested after 48 hours of incubation. Since 
ste2-
A265T mutant was similar to the 
ste2-A295T mutant as tested by quantitati
mating and
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ste2-A295T
a- factor
AN-
antagonist
ant +a - factor
DMF
AN-
a- factor
ka- factor
Figure 5. Halo assay of the suppressors in the wild-type background to
partial agonists. The order of the ligands is indicated on the left side of the
culture plates. ka-factor is kluyveri a-factor. AN-37 and AN-44 were
diluted in dimethyl formamide (DMF); DMF alone does not result in halos
as shown in figure.
onist uence o onist iameter in cm
STE2+ ste2- A229T ste2-A295T
a- factor WHWLQLKPGQPMY 1.8 2 (1.lx)(1.lx)
I . 
h,,?
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desTrp 1 Ala3 HALQLKPGQPMY the antagonist results in no haloes
AN- CRGPQLKPGQPMY 1.25 (1.56x) 8 (Ix)
AN- WHWLSLGGRQPMY 1.65 (1.65x) 1.65
(1.65x)
kluyveri WHSFSKGEPMY 1.4 (1.64x) 1.5
(1.76x)
Table III. Responsiveness of the suppressor mutations to parial agonists
was analyzed by halo assays conducted using the agonist, antagonist and the
parial agonists of the yeast pheromone receptor. The actual halo sizes are
given, the fold induction with the receptor mutations compared to the wild-
type receptor are indicated in parenthesis. AN-37 and AN-44 were diluted
in dimethyl formamide (DMF); DMF alone does not result in halos.
by ~-galactosidase assay, this qualitative difference in halo size is likely to be a
consequence of an increased role of adaptation for the 
ste2-A265T. As was the case with
the wild-type, neither mutant was found to signal with the antagonist DesTrp 
1 ,Ala3-a-
factor. iI'
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sin di estion assa . As shown previously (Chapter II), the 
ste2- T274P mutant
receptors fail to undergo detectable agonist-mediated conformational change as 
determned
':1
;"L
":!, '
by the in vitro proteolysi assay (also Chapter il, compare panels A and B of 
Figue 6).
The expectation therefore was that the 
ste2-1274P mutation in combination with the
suppressor mutation would lead to an a-factor-inducible conformational change similar to
that of the wild-type. Since the suppressor mutations result in an increased basal activity as
determned by the activity of the a-factor-inducible reporter gene, it was also anticipated
that they wou1d influence the allosteric equilibrium. 
If the suppressor mutations resulted in
an increase of the R * state of the receptor, in the absence of agonist
, they would be
expected to have cleavage patterns that resemble the wild-type in the presence of a-
factor.
This issue can be addressed by comparng the cleavage patterns of the membrane
preparations containing either wild-type receptor, the 
ste2- 1274P mutation, the suppressor
mutations, and the suppressor mutations in combination with 
ste2-1274P.
The diffculty with comparng digestion patterns from different membrane
preparatio is that the overall rate of trypsin digestion is influenced by other proteins that
compete for the enzyme activity. The quantity and the quality of these competinG-
protei
vary among the different membrane preparations . Including an internal control would
standardize these varations among the different membrane fractions. Trypsin digestion
results in two major cleavages of the receptor; cleavage #1 results in the formation of
receptor fragment F2, and cleavage #2 results in the formation of receptor fragment F3.
A. 1 2 3 4 5 6 7 8 910 11 1213
B. 1 2 3 4 5 6 7 8 9 10 11 1213
1 2 3 4 5 6 7 8 9 10 11 1213
."" F2
2. 3 4 5 6 7 8 910 11 12.
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Figure 6. Membranes prepared from cells with the different receptor alleles;
wild-type (211- 3), B. ste2-T274P (902- l), C. ste2-A229T,T274P
(1382- l), D. ste2-A229T (1381- l), were incubated with trypsin for the
indicated number of minutes in the presence or absence of agonist. The
resulting cleavage products were analyzed by SDS-P AGE and
immunoblotting methods. The antiserum was against the N termnus of the
receptor. The control reaction was incubated for 100 minutes in the absence
of trypsin and agonist (lane 13). The major cleavage products are indicatedon the right. 
:. 
Ratio of the cleavage rates at position #1 and positio
#2 provid a diagnosti indicator for
the conformational state of the receptor. Although the cleavage pertnent to activation is
cleavage #2, includig the rate of cleavage #1 provid
an internal control for each
membrane preparati III 'CI.
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The trypsin assays were performed as described in Chapter 1. Crude membranes
were prepared from wild-type cells as well as from cells containing the 
ste2-1274P
\H.)' '
mutation, the suppressor mutations, and the suppressor mutations in combination with
ste2-1274P. Membranes were incubated with 
trpsin with and without agonist (even and
odd numbered lanes, respetively) and at varous time 
points, cleavage products were
, ,
. 0"\
detected by using Western blot analysis. The relative rates of cleavage was infeued by
estimating the time at which 50% of Fl is converted into F2 (for cleavage #1) and the time
. t: ::
. .. .
at which 50% of F2 is converted into F3 (for cleavage #2); the ratio of these two time
points reflects the relative cleavage rates. As 
sumared in Table IV, cleavage #1 occurs
by 1 minute for wild-type receptor both in the absence and the presence of a-
factor.
Cleavage #2 in the absence of a-factor is by 10 minutes, and addition of a-
factor decreases
this period to 5 minutes. The ratio of cleavage #2 to cleavage 
#1 was found to be 10 in the
absence and 5 in the presence of agonist for the wild-
type, whereas the ratio of the
ste2- 1274P was found to be 30 in the absence and 50 in the presence of a-
factor. Hence,
as concluded in Chapter n, the defects in the 
ste2- 1274P mutant receptor interfere with the
abilty of agonist to enhance the relative rate of cleavage at positi
#2. Accordig to this
criterion, the ste2-T274P mutant receptor is more in the inactive conformation than the
unoccupied wild-type receptors.
Figure 6 , panel C shows the cleavage pattern obtained with the suppressed mutant
ste2-A229T, T274P. With this mutant, 50% ofF2 was converted to F3 by 5 minutes
(panel C, lane 5) in the absence of a-factor, and ths process was slowed to 10 minutes in
the presence of agonist (panel C, lane 8). 
The relative cleavage rates for
strai Cleavage 1 Cleavage2b ratio of 2 to 1 
-a- +a- -a- +a- -a- +a-
STE2
100 1.5
Ste2-T274P
ste2-A229T ,T274P
ste2-A265T ,T274P
ste2-A295T ,T274P
1.5
ste2-G 163D,T274P
ste2-A229T
ste2-A265T
ste2-A295T
ste2-G 163D
1.7
Table IV. Tabulated results of trypsin digestion assays with membranes
containing wild-type receptor (STE2), and the receptors containing the
ste2-T274P mutation, the suppressor mutations with the ste2-T274P and the
same mutations in an otherwise wild-type background. The digestion
pattern was analysed by Western blotting methods at 0,1,5,10,30 and 100
minutes, except for the ste2-A229T which was analyzed at 2 min.s in
addition to the above.
a Cleavage 1 is the time in minutes when amounts of F1 versus F2 were
approximately equal.
b Cleavage 2 is the time when amounts of F2 versus F3 were approximately
equal (1 10,30 and 100 min). When equal amounts of the two
intermediates occured between two time points , the mean value was
assigned (i. , time interval between 1 to 5 min was 3, between 5 to 10 min
was 7, between 10 to 30 min was 20, and 30 to 100 min was assigned a
value of 65).
100
Last column is the ratios of Cleavage 2 to I in the absence and the
presence of a-factor respectively.
Strains used are 211- (STE2), 1379- (ste2-G163D, T274P), 1380-
(ste2- G163D), 1381- (ste2-A229T), 1382- (ste2-A229T, T274P),
1389- (ste2-A265T), 1390- (ste2-A265T T274P), 1391-c
(ste2-A295T), 1392- (ste2-A295T, T274P) and 902- (ste2-T274P). ,I,,ti
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ste2-A229T, 1274P mutant both in the absence and presence of agonist differed from what
was observed for ste2- 1274P mutant alone, and more closely resembled the pattern
observed for wild-type receptors in the presence of a-factor. The same results were
obtained with the rest of the suppressor mutations in combination with the 
ste2-1274P
it I '
mutation, Table N. Figure 6, panel D depicts the digestion kinetics of the 
ste2-A229T
mutant; whereas the cleavage that gave rise to F2 was slowed by a-
factor, as was observed
tWo;
,,;"
:iH ,;
for wild-tye receptors, the cleavage that gives rise to F3 was not enhanced by a-
factor
upon addition of a-factor. The trpsin digestion assays revealed 
that the cleavage rates of
:l,:
J : 
all four suppressor mutations (both in an otherwise wild-type background and in
combination with the 
ste2- 1274P mutation) resemble the wild-ty rather than the :t'
ste2- 1274P mutation. Of the rest ofthe suppressor mutations, the 
ste2-G163D displayed
factor induced exposure of the thid loop, whereas the ste2-
A265T and ste2-A295T
receptor mutants did not. In conclusion, the presence of 
the suppressor mutation causes
the wild-type and the ste2-1274P mutant receptors to assume a conformation that resembles
the a-factor-activated state. The fmding that the thd loop 
shows a high rate of cleavage
both in the presence and absence of a-factor in the suppressed receptor mutants none of
which are constitutively active is surprising and it suggests either that the balance between
the R and R * states in the in vitro assay differs from in vivo 
case or that exposure of the
thid intracellular loop is not sufficient to cause constitutive activation of the post-receptor
signal.
Interaction with the G- roteins. Since most of the suppressor mutations are close to
the intracellular loops, they could be enhancing mating by altering interactions with G-
proteins. This point was addressed by a genetic test developed by Kim Schandel. 
This test
is based on a synthetic lethal phenotype of the 
gpal-A345T mutation that was identified as
a suppressor of the ste2-L236H mutant. The ste2-L236H 
mutation leads to an amino acid
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change in the third intracellular loop and results in decreased responsiveness to a-
factor
(Schandel and Jenness 1994). The gpal-A345Tmutati was found to reverse the
signalling defect of this mutant receptor ( Schandel, K.A. and Jenness, D.D., unpublished
work). In addition to its abilty to suppress the receptor mutation, the gpal-A345T
mutation leads to the constitutive cell-cycle arest at 38 C. Ths phenotype 
is consistent
with instabilty of Gpal p at 38 C and with a consequent failure to bind the G~y subunits.
This 38 C phenotype is exacerbated in a ste2 deletion background. This observation
provides a convenient way to test whether the mutant receptors retain contact with the G-
protein. If the receptors containing the suppressor mutations had lost the stabilzing
interactions with the mutant G-protein, the double mutant would be temperatue-sensiti
for growth. No synthetic lethal phenotype was detected for the double mutants containing
gpal-A345Ttogeth with ste2-T274P, ste2-G163D, ste2-A229T, ste2-A265T and ste2-
A295T.
Discussion
In an attempt to identify factors involved in the activation of the pheromone
receptor, I used a genetic screen to isolate suppressor mutants that alowed the inactive
ste2- 1274P receptor to become more active. No allele-specific extragenic suppressors
were found in this screen. Extragenic suppressors would have potentially identified gene
products that interact with the receptor and affect the allosteric transition. However
, four
intragenic suppressors were found to alleviate (at least parially) the receptor defects caused
by the ste2- T274P mutation. Interestingly, all four mutations mapped to the ends of the
transmembrane helices implying that allosteric transition involves cooperative interactions
among transmembrane helices IV, V, VI and VI. This provides further evidence that the
ste2- T274P mutant receptor is defective for allosteric transition; as opposed to a simple
103
bindig-site defect. It is also interesting that all of the suppressors resu1ted in the
substitution of a polar residue in place of the existing non-polar residue. In light of 
ths
fact, one possible mode of action of the suppressor mutations could be to "stretch" the
helices out of the membrane. In this respect, it is noteworthy that one of the suppressor
q In:,
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mutations (ste2-A229T) affect the N-termnus of the thid intracellular loop which 
exposed to the cytoplasm upon a-factor binding. A varety of evidence implicates the
exposure of the thd loop to the cytoplasm and to G-protein in the activation of both
mamalian and yeast receptors (Boure 1997; Hogger et al. 1995).
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Since the reversal of mating defect was the basis of selection, it was expected that
all the suppressed mutants would exhbit increased mating as compared to the
;c;
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unsuppressed ste2- n74P mutant in the quantitative mating assay. This expectation was
borne out. All four suppressor mutations led 
to increased mating in the ste2-1274P
\:-':';.
background. Determnation of ICso values of the suppressor mutants for a-
factor in either
the ste2- n74P or otherwise wild-type genetic background led to the conclusion that three
of the four mutant receptors have close to a wild-type Kc value, whereas the 
ste2-1274P
receptors exhibit a value that is significantly greater than the wild-type. The Kc of the
ste2-G163D, 1274P mutant gave an intermediate value, whereas the ste2-
G163D single
mutant had wild-type Kc. In support of the idea that the ste2- n74P 
mutant is not a simple
binding-site mutant, the residues affected by three of the suppressors were not readily
accessible to the extracellu1ar ligand.
One of the expected results was that the suppressor mutations would lead to a
reversal of the conformational defect of the 
ste2- n74P mutant receptor, as detected by the
limited-trpsin digestion assay. I suspected that the receptors from the suppressor mutants
would be in a more activated state than the wild-type receptors even in the absence of
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agonist. According to previous findings (Wess 1997), ths activated state is thought to be
a less-constrained state, in which the conformation of the intracellular loops would allow
producti coupling to the G-proteins. Analysis of my data revealed that the relative
cleavage rates in the C-termnal tail and the third 
intracellular loop were more disparate in
the ste2- 1274P receptor than in the wild-type receptor. In the absence of a-
factor, the
suppressor mutants exhbited an increase in the cleavage rate of the 
thd intracellular loop
compared to the cleavage in the C-termnal tail. 
However, upon a-factor addition,
accumulation of fragment F3 that resu1ted from this cleavage was not enhanced
significantly compared to wild-type receptors. Results of 
the trpsin assay suggest that
the effect of the suppressors is to relax the overall receptor 
strctue, makg the thid
intracellular loop more accessible to trpsin. In the 
mamalan system Gether et al. (1997)
and Samama et al. (1997) both showed that the unoccupied receptors with constitutive
activity were more susceptible to proteases as assessed by a loss of binding sites 
afer
incubation at 37 C; addition of ligand (agonist or antagonist) increased stabilty,
presumably by constraining the receptor. Although in the absence of agonist, the digestion
pattern of the receptors from the suppressor mutants resembles the digestio
pattern of
wild-type receptors in the presence of agonist, the suppressor mutations do not result in
strong constitutivity, in that they do not lead to constitutive cell-cycle arest. 
This suggests
that the exposure of the thid loop which can be detected by the 
trpsin assay is not the only
essential criterion for activation or that receptors in the 
in vitro assay are not as constrained
as they are in vivo.
The activating effect of the suppressor mutations on the overall receptor structure
was corroborated by measurng the level of activity from an a-
factor inducible reporter
gene. One difficulty in comparng the relative 
levels of signalling among the different
receptor mutants is that the observed levels of signalling (both constitutive and inducible)
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may be limited due to decreases in the number of the mutant receptors. Nevertheless, 
was observed that the suppressor mutations by themselves lead to a higher basal activity
than the double mutants containing the same suppressor mutation together with the
ste2- T274P. Since the increased basal activity did not in general correlate with increased I :
receptor number, it appeared that ste2- 1274P constrais the receptor in a less active
conformation. The increase in basal activity seen with the receptors with suppressor
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mutations was used to differentiate between the two possible models underlying the
inactivation of the ste2-T274P mutatreceptor. The ste2- T274P 
mutation cou1d result in a
,;,
change either in the alosteric equilibrium (the ratio ofR to R*) or in the relative afnity of
.. ""
the two states for the agonist. The reversal of inactivation could also be a consequence of
either mechansm. Hence there are four possibilties for the inactivation and suppression of
the mutant receptors. These four models make different predictions for the basal level of ~-
':
1.j
galactosidase activity in the 
ste2- T274P, suppressor and the double mutant (Figues 7A and
7B).
Modell. If the ste2- 1274P changes the relative affnity of either state for the agonist, the
basal levels wil not be afected by this mutation since basal signalling does not involve the
addition of agonist. If the suppressors reverse this defect, the basal levels of the
ste2- 1274P, suppressor in the ste2- T274P background, and suppressor by itself would all
be the same (Figure 7 A).
Model 2. If the ste2- 1274P altered the relative affnity, and the suppressors affected the
equilibrium of the two states , then the suppressors both alone and with the 
ste2-T274P
mutation would have higher basal levels than the 
ste2- T274P (Figure 7 A).
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I. If Ste2-T274P aft ects the binding site of the R* fo 
Model 1. Suppressor changes back t he binding site
Model 2. Suppressor alters the equilbrium in favor of the R* form
Figure 7 A. Affect of mechanism of suppression on basal levels of signallng
when the ste2- T274P alte rs the binding site.
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II. If Ste2-T274P alters the equilbrium between Rand 
weaker 
Model 3. Suppressor alters the binding site
Model 4. Suppressor changes back the equilbrium
Figure 78. Affect of the mechanism of suppression on basal levels of signallng
when the ste 2- T2 74P alte rs the alloste ric equilibrium.
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Model 3. If the ste2- 1274P affected the equilibrium, and if the suppressors altered the
relative affinity; the basal levels with the 
ste2- 1274P would be expected to be lower than
wild-type. However, experimentally, the basal level 
wil be essentially unaltered because
the basal signal originatig from the receptor is small compared to the level of signal that
arises from post-receptor signals. In this scenaro, the presence or absence of the
suppressor mutation is not predicted to have any effect on the basal signalling levels
(Figure 7B).
Model 4. If the ste2- 1274P mutation and the suppressor mutations have opposing
influences on the allosteric equilibrium (Figure 7B). In this case, the 
ste2- 1274P mutant is
predicted to signal less than wild-type , and the suppressor in the 
ste2- T274P background is
predicted to show an intermediate level of signalling, and the suppressor mutation is
predicted to signal more than wild-type. The basal level of suppressor in the 
ste2-1274P
background would depend on the strength of the suppressio
. If the suppressor mutation
reverses the effects of the 
ste2-T274P mutation back to wild-type levels, then the basal
level would be the same as 
ste2- 1274P by itself. If the suppressor alters the equilbri
such that there was more than wild-type levels of R *
, than the basal signalling would be
higher. Regardless, the suppressor alone 
would have an increased level of signalling
relative to the suppressor in the 
ste2- T274P background in this model.
The observations of the transcriptional induction assay are the following:
1. Suppressors in an otherwise wild-type background have high basal levels which rules
out Models 1 and 3.
2. Suppressors with the 
ste2- T274P mutation have a IQwer basal level than suppressors
alone which rules out Model 2.
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Therefore the experimental results are consistent only with Model 4. The basal
levels of ~-galactosidase activity in the suppressed ste2- 'f74P mutant was signficantly
greater than either wild-type or the ste2- 1274P single mutant. Ths suggests 
that the
ste2- 'f74P mutation leads to an alteration of the allosteric equilbrium and the suppressors
have the opposite effect. A fuher increase in the basal levels is expeted to occur if the
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receptors containing the suppressor mutations are over-expressed since the accumulation of
receptor protein in the suppressor mutants was lower than that observed for wild-type
receptors. Examples of constitutively.,active ~2-adrenergic receptors have been described
. f'
;1".
in which the receptor protein is unstable and the addition of either agonist or antagonist
increases the levels of accumu1ation (Gether et al. 1997; Samama et al. 1997).
, !!
Considerably higher basal levels were observed with the constitutively active mutant 
ste2-
P258L when it was over-expressed; this mutant on a single copy plasmid had protein levels
: .',
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comparable to wild-type, but the Bmax was 4 times less than wild-type (Konopka et al.
1996) implying that a minority of the receptors were at the cell surace. Birbaumer and
colleagues have shown that a 6-fold decrease in Type 2 vasopressin receptors causes a 60-
fold increase in the ECsO as well as a decrease in the maxmal stimu1ation (Birbaumer et
al. 1994). Decreased levels of receptor protein accumulation could also be the reason for
the lower level of signalling ' (compared to wild-type) that was observed when the
ste2-A229T, 1274P mutant was treated with a-factor. It is also possible that this mutation
leads to the induction of a desensitization mechansm, resulting in lower maxmal
signalling.
I suspect that the suppressor mutations do not have an all-or-none effect on the
allosteric transition but instead decrease the difference in the free energy between the Rand
the R * states since these suppressors do not lead to strong constitutivity. Generally,
GPCR activation is not thought to alter the receptor structure in a major way, but is thought
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to affect intracellular loops as a result of subtle changes in the transmembrane helices (Wess
1997). Consistent with ths idea, the positions of the amno acids affected by the
suppressors implicate the involvement of the second and thid intracellular loop as well as
the carboxy-termnal tail in receptor activation. The two strongest suppressor mutations
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ste2-A229T and ste2-A295T affect residues that are conserved in distantly related
pheromone receptors (S. cerevisiae, S. kluyveri and S. pombe. The ste2-A229V mutation
Siil
which was identified by Marsh and colleagues was found to result in increased
responsiveness to antagonist, cerevisiae 
factor and the kluyveri factor (Marsh
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1992). This provides additional evidence for involvement of ths residue in conformational
change.
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DISCUSSION
Saccharomyces cerevisiae was used as a model system for understanding the
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mechansm by which G-protein-coupled receptors are activated. The yeast pheromone
response pathway consists of a G-protein-coupled pheromone receptor and a matig-
r::
specifc MA kinase casade (Leberer et al. 1997). Although yeast containing multiple
MA kinase cascades (Herskowitz 1995), there is a single pheromone receptor and it
n1, II,
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shares the general molecular architectue with the mamalan receptors. Given the ease
with which laboratory mapu1ations and advanced genetic analysis are performed with :z;l
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yeast cells, the presence of a yeast GPCR provides an ideal system for studying the
mechansm of receptor activation. Moreover, yeast provides a "cleaner" system as there is
no interference from multiple G-proteins as there is in the mamalian cells.
i '.11:
The strctual simarity among the members of this superfamly of receptors that
bind a diverse range of ligands suggests that the different receptors share mechanstic
featues for their activation. Although extensive computer modellng has been performed
with the transmembrane regions of several GPCRs, lack of strctual information makes it
diffcult to evaluate the accuracy of these models. Most contrbutions to the activation
mechansm of GPCRs comes from work with rhodopsin that has spectrally-distinct R and
R * forms. This propert makes it useful for analysis of mutations that activate or inactivate
, as well as for biophysical dissection of the activation process. As mentioned in the
introduction the chromophore II-Gis-retinal associates with the apoprotein by formng a
Schiff base with residue Lys296 in transmembrane 7 , and this association stabilizes the R
state of the receptor. The Glul13 in transmembrane 3 provides the counterion for the
Schiff base. The activation of the receptor by a photon results in the isomerization of the
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II- cis to II- trans retinal and the disruption of the salt-bridge between TM3 and TM7 (Rao
and D. 1996). Transition to the R * state of rhodopsin also requires the protonation of the
D142 at the cytoplasmic end ofTM3. Ths residue is a par of a conserved motif (DRY)
found in most GPCRs (DRY however is absent in the STE2p). Computer simulations and
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site-directed mutagenesis of the alB-adrenergicreceptor, were used to suggest that the
interaction among polar residues on the cytoplasmic portons of the receptor contrbute to
the stabilization of the R state. The disruption of these interactions involving Asn63,
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Asp91, Asn344 and Tyr348 (TM 1, 1; 2, and 7 respectively), is thought to cause the R143
residue to exit this "polar pocket" and to become more exposed to cytoplasmic environment
(Scheer et al. 1996). Apar from the DRY motif, the presence of a hydrophobic residue in :Z":
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the second intracellular loop was found to be important for the coupling of G-proteins to
adrenergic and muscarnic receptors (Moro et al. 1993). Time-resolved spin-label studies
have indicated the involvement of the second intracellu1ar loop of rhodopsin in activation as
well (Farahbaksh et al. 1995).
;',
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The importance of the thid intracellular loop of the receptor in G-protein coupling
and activation has been underscored by mutations that affect this region of the receptor and
111
result in a constitutively-active phenotype. The third intracellular loop is thought to have an
helical strctue, and this secondar strctue as well as the sequence identity were both
found to influence G-protein activation (Frane et al. 1992; Burstein et al. 1996). Apar
from examning the individual role of each intracellular loop, the cooperative effects of the
loops 2, 3 and 4 (formed between TM7 and and the site ofpalmitoylation in some GPCRs)
in the activation of G-proteins have also been investigated. One study pertaining to the role
of the intracellular loops employed the use of synthetic peptides corresponding to these
regions in competition binding studies with rhodopsin and Gt (Konig et al. 1989). It was
found that two peptides showed synergy in competing for binding of Gt with activated
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rhodopsin; this effect was thought to be due to the stabilzing effects of the peptides on the
R * form of rhodopsin.
Analysis of two-dimensional rhodopsin crystals have allowed the calculation of a
three-dimensional map for the transmembrane helices, including the tilt angles (Unger et al.
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1997). This work concludes that helices 2 and 3 are positioned such that they separate
helices 6 and 7 and helix 4. The transmembrane helices are positioned such that the
:;1'
extracellular surace is more open (allowing ligand binding) and the cytoplasmic porton is
more closely packed. Ths model is consistent with the curent ideas for receptor activation
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which suggest that the cytoplasmic pocket opens up to create new sites for contact with the
protein.
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The activation mechansm of the yeast pheromone receptor STE2p is not
understood as well as the mamalian GPCRs. Work by Sen and Marsh (1994) indicates
that the ligand-bindig site is likely to involve contacts in mu1tiple transmembrane domais
since mutations within multiple transmembrane segments alter ligand binding specificity. Y"I':
Separate studies from Clark et al. (1994), Schandel and Jenness (1994) and Stefan and
Blumer (1994) confIrm the importance of the thd intracellular loop in signalng for Ste2p
III
as established for mamalan receptors. Systematic alanne substitution of the intracellu1ar
thid loop (Clark et al. 1994) was used to identify determnants of signalling; it was
concluded that the general aspects of the loop strctue are more important than specific
residues. The importance of the transmembrane domains in receptor activation was shown
by two groups. Konopka et al. (1996) showed that the Pro258 on TM6 , one of the few
conserved residues between the yeast receptor and mamalian systems , is important for
maintenance of the inactive state since the ste2-P258L mutant shows constitutive activation.
Unlike the constitutively activating mutations of the mamalian receptors which are
dominant, this mutation was found to be parially dominant. In order to identify sites
important for receptor activation, Sommers and Dumont (1997) took the approach of
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targeting a paricular transmembrane region for mutagenesis. This work identified residues
in the thid transmembrane helix that result in loss-of-function ste2 aleles; the affected
residues were I142N, E143K and Tl44P. The second site suppressors of these ste2 alleles
affected the first (R58G), fifth (M218T), and the sixth (Y266C) helices suggesting either
diect physical interaction between those residues or a more indiect or global stabilization
of the receptor. The same work in addition showed that substitution of the only acidic
1;1
'II 
;l1:f1l1
!:'
rq;"
01 
1i;?':
residue on TM3 does not afect function. Ths is unlike some mamalan receptors where
the acidic residue acts as the counter-ion for the ligand. Thus, this fmding rules out the
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argument that the basic residues on a-factor (histidine and lysine) requie interaction with ':;,II
this residue.
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In order to study the activation mechansm of the yeast a-factor pheromone
receptor, I stared out by developing an in vitro assay that was sensitive to ligand-induced
changes of the receptor. Using limited trypsin digestion, I showed that binding of the
", .
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agonist resu1ts in the enhanced cleavage of the thd intracellular loop. The same ligand-
induced changes in the digestion pattern were also obtained with membrane preparations
from strains lacking G-proteins; this suggests that the exposure of the thid loop upon
binding of agonist is an inerent property of the receptor and not an indirect consequence of
protein dissociation. Moreover, a mutant receptor (ste2-L236H) that affects the thid
loop and is defective for G-protein coupling retained the abilty to undergo the agonist-
induced conformational changes. These results are consistent with a model in which G-
protein activation is limited by the availability of specific contacts between the G-protein
and the thid intracellular loop of the receptor. This finding correlates with work from
mamalian GPCRs which implicate an important role for the third intracellular loop in
receptor activation (Hogger et al. 1995; Bourne 1997) as well as work in yeast. The
agonist specificity of the third intracellular cleavage was tested by performng trypsin
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digestion experiments in the presence of the antagonist, DesTrpl, Ala3-a-factor. The
antagonist was found not to accelerate the cleavage of the thd loop; in fact, its presence
resulted in the deceleration of all cleavages. This suggests that binding of the antagonist
promotes a distinct form of the receptor that is different than both the unliganded and
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agonist-bound form of the receptor.
In Chapter II, I describe the isolation and the characteriation of a non-signalling
receptor mutant, ste2- n74P. I took the approach of randomly mutagenizing the STE2
:W:.:;lt
:"II
: l
:i.
gene in order to prevent bias toward a parcu1ar residue or a region of receptor. The non-
signalling receptor mutant exhbited a low-afnity for a-factor; upon addition of satuating !;t
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amount of the agonist, it was found to be endocytosed and to signal like wild-type receptor
and yet in vitro it faied to undergo the agonist-induced conformational change at satuating
levels of a factor. These results points to an apparent discrepancy between the in vivo
....'
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(endocytosis and signalling) and in vitro (conformational change) assays. One possible
explanation is that the change detected by the trpsin digestion assay that is pertinent to
N. II:
activation is the only one to be impaired in the ste2- 1274P and that other changes that occur
upon the addition of agonist are suffcient for the endocytosis and weak signalling
functions to be observed. Another possible explanation is that a factor that stabilizes the
active form of the mutant receptor in vivo is lacking under the conditions of the trypsin
assay. In other words, the allosteric parameters are less stringent under the conditions of
the in vitro assay. The fact that the mutation results in reduced affmity for agonist and an
increased affnity for the antagonist are consistent with the ste2- n74P mutation affecting
both the conformational change and the binding site. The observation that the effect of the
mutation on dose-response is more extreme than the effect on binding affinity are
inconsistent with a simple alteration of the ligand-binding site.
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Two types of strctual defects could account for the failure of a mutat
receptor to undergo an allosteric transition: The defect cou1d resu1t in increased free energy
for the R * form or decreased energy for the R form, alternatively, it could result in an
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fXialteration of the ligand binding site that reduces the relative affInity of agonist for the R 
form of the receptor. One way to diferentiate between the two possibilties is to examne
?":
the Effect of the receptor mutation on the basal levels of signalg. A mutation that
changes the allosteric equibrium in favor of the inactive form of the receptor would be
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1i: il'expected to decrease basal activity. Ths can not be tested diectly in yeast because post-
receptor signalng leads to the majority of the basal signal; deletion of the STE2 gene :3Y
';;:1!
:c(" !i"
-:11
jjI.results in even a higher basal level. An indiect way of testing the Effect of the 
ste2-1274P
mutation on basal levels was to examne the effect of 
ste2- 1274P on a receptor mutant that
iil
)11exhbits higher levels of basal signal.
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Suppressors of the ste2- 1274P were sought in order to identify other
residues involved in the alosteric transition as well as to define the specific defect in the
111
ste2- T274P mutant receptor. The second site suppressors of ste2- 1274P as well as the
initial ste2- T274P mutation itself have a commonalty in that they affect residues at the end
of transmembrane helices; these regions are thought to he involved in receptor activation
(Luo et al. 1994). The second site suppressor mutations result in the substitution of non-
polar to polar residues and affect the fourh, fifth, sixth and the seventh transmembrane
helices; these TM helices are connected to i2, i3 and the carboxy-termnal of the receptor.
Therefore, the positions of the primar defects in these mutants underscores the
involvement of the second and thid intracellu1ar loops as well as the carboxy-termnal tail
in receptor activation. Ths is consistent with the notioJ; that multiple intracellular receptor
domains are involved in receptor activation and G-protein coupling (Shi et al. 1995). My
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findings are also consistent with the computer-generated simulations of the trptane
receptors which suggest that agonist binding causes a rotation of helix 7 that is coupled
with the rotation of helix 6, with lateral transition of helix 4 and ultimately with the
exposure of the the third intracellular loop (Luo et al. 1994; Zhang and Tipper 1993).
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The suppressor mutations were fuher characterized by determning mating abilty
and agonist afnity. As expected, al four of the suppressor mutations reversed the mating
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defect and reduced a-factor afnity of the ste2- T274P mutant. The transcriptional
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induction assay revealed that at least two of the suppressors increased the basal level of
signallig. Moreover, the suppressor mutant enhanced responsiveness to certain a-factor
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analogs as assessed by halo-assays. Both of these findings are consistent with the idea that
\jj:
!1C
l:!
1"t
" '
liI
I 1 Ii!
J- '''
: ;. . ;.'
the suppressor mutations cause the receptor to be poised towards the more activated state
(R*). The analysis of the trpsin digestion data are also consistent with this idea since the
relative cleavage rate of the thid intracellular loop was found to be increased in the
y
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unoccupied receptors in the suppressor mutants, resemblig the activated state. Activated
forms of receptors are thought to assume a more relaxed state which may resu1t in enhanced
protease cleavage (Scheer and S. 1997; Gether et al. 1997; Samama et al. 1997). 
surprising finding is that the addition of a-factor does not lead to a fuher enhancement of
the accessibilty of the thid intracellular loop. This is surrising since the addition of a-
factor results in increased signalling that is comparable to wild-type. One possibilty is the
difference between the in vivo and in vitro conditions; it could be that 
in vivo the thd loop
is more exposed upon the addition of agonist. Second possibilty is that further exposure
of the third intracellular loop is not a sufficient criterion for signalling; changes in other
pars of the receptor are capable of additional signalling observed in the presence of
agonist. Data that provides support for this notion comes from Kim et al. (1997) where
electron paramagnetic resonance (EPR) spectroscopy was used to determne the domains of
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rhodopsin that move upon photoactivation. Comparison of the EPR spectra of the
photoactivated wild-tye and the constitutively-active mutat in the absence of agonist
detected similar motion at TM 3 and 7, whereas only the wild-type rhodopsin showed
movement at TM6 upon photoactivation. This suggests that different domains can move
independently and argues against concerted changes in receptor. Another point of interest
is, although the third loop is exposed in the suppressed receptor mutants even before the
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addition of a-factor, this alone is not suffcient for strong constitutive signalling although
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the suppressor mutations result in increased basal levels. Since some of the suppressor
mutations decrease the protein levels of the receptor, it cou1d be that if protein levels were
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identical among the receptor mutants, they would exhbit higher basal activity.
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Second site suppressors are often associated with global stabilzation of the protein.
If this were the case with the suppressor mutants analyzed in this work, they would be
expected to alleviate the defects of other receptor mutants that harbor strctual defects.
But, since the ste2- n74P binds the antagonist, it is unlikely to have an unstable strcture.
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Aside from the global stabilzation, the second site suppressors identified in this work are
thought to stabilze the R * state of the receptor. The effect of the suppressors on the
stabilization of the R * form of the receptor can be tested with other loss-of fuction ste2
alleles such as those identified by Sommers and Dumont (1997).
According to the Ternar Complex Model which is used to study the activation
mechanism of GPCRs , there are two forms of the receptor; the inactive form (R) and the
active form (R *). The Ternar Complex Model (TCM) is a derivatization of the Monad
Wyman, Changeux s two-state model that was proposed to explain the characteristics of
hemoglobin in the inactive and the active form which have distinct crystal structures. This
idea of two forms of hemoglobin is being challenged by the finding of three energy states
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for the protein (Ackers and Smith 1987). In the GPCR field, recent findings have also led
to the suggestion that multiple form of receptor exist and that each form displays unque
characteristics for binding to the G-protein. A mutation in the (lIB-adrenergic receptor
which results in higher affnity to agonist and a slight increase in basal levels but does not
show induction with agonist suggests the presence of more than one R * form (Scheer et al.
le,
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!ti1996). Another mutation in the alB-adrenergic receptor which couples to two different
effectors was shown to constitutively activate only the phospholipase C but not the
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phospholipase A2 pathway (Perez et aI. 1996). The idea of different forms of GPCRs is
also suggested by work with negative antagonists. Work from Samama et al. (1994) and
Barker et al. (1994) indicates that ligands can serve as inverse agonists for signal
transduction even though they elicit a conformational change and cause increased
- ;:';,;,
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endocytosis of the receptor. My findings provide fuher evidence for the presence of
multiple forms of the receptor in that the antagonist, DesTrp 1 ,Ala3-a-factor promotes a
, '
11:
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highly constrained conformational state in vitro that differs from the unoccupied or agonist-
occupied state.
1/ ' III:
The extended TCM model states that only the R * form interacts with the G-
protein. This does not appear to be a general featue of GPCRs since examples have been
found where receptor- protein complexes can be co-immunoprecipitated in the absence of
the agonist (Okuma and Reisine 1992). A rhodopsin mutant that can bind G-protein but
not activate it argues against this facet of the model as well (Frane et al. 1990). The
stabilzation of the temperature-sensitive Gpalp (gpal-A345T) by the ste2- 1274P mutant
receptors (locked in the R state) suggests that the R form of the Ste2p can also interact with
proteins (K.A. Schandel and D.D. Jenness, unpublished). Recently, the extended
model has been modified further and the modified model has been referred to as the
general model" ; this model takes into account the interaction between G-proteins and
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inactive receptors and the presence of more than two states of the receptor (Figue 1; Fong
1996). Neverteless, these complications underscore the complexity of the mode of
activation of the GPCRs and point to the need for combined approaches in this field.
In summar, although the a-factor pheromone receptor does not share sequence
homology and lacks most of the conserved motifs of the mamalan GPCRs, its structue-
function relationships seem similar to the mamalian GPCRs. As in mamalian systems,
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exposure ofthe thid loop was foundto be an important, although perhaps not the sole
determnant of receptor activation. There wil undoubtedly be discrepancies with the
Q.::i:
~~~
11O:lt
',j!r
ktlt
mamalian systems since certain evolutionar pressures (such as providing selectivity for
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the specific G-protein) in higher eukarotes do not apply in yeast. IJ!
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A. Ternary complex model B. Exended model
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C. General model
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G prot ein binding
Figure 1. Thermodynamic models of GPC activa tion. A and B
are the same as Rgure 2 in Introduction. C. shows receptor can
undergo thr ee processes eithe r separate Iy or simulta neously.
This also iIustr ate s tha t the agonist can bind to the receptor
in 4 different states with 4 different affinities. From Cell.
Signal. 8, 217-224, 1996, T.M. Fong.
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APPENDIX
This section contains a summar of experiments that were stared as preliminar work as
well as suggestions for future experiments.
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I. Experiments with the SST211 strain
':'~~~
SS12 is a negative regulator of the pheromone response pathway; its deletion leads to f,1, :lt
q:;;,
enhanced signalling. It is thought not to interact diectly with the Ste2p because of the
following:
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1. Ste2 deletion stil gives an sst2 deletion phenotype (Konopka and Jenness 1991).
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2. Deletion of SS12 and the Ste2- T326 mutation have synergistic effects on sensitivity.
Synergy suggests that these two gene products affect two different pathways. This result ,1'. 111:
also indicates that the C-termal domain of the pheromone receptor is not required for
interacting with Sst2p (Konopka et al. 1988).
3. Linker scaning mutations of the STE2 gene have resulted in the finding of an N-
termnal mutated Ste2p which signals in an sst2- strain. Cells with the ste2-IlOl mutation
produce no halos, but the ste2-IlOl sst2- double mutant produces halos. Allele-specific
suppression could be indicative of interaction between the two gene products. It could also
mean that wild- type SS12 dampens the signal via another protein and loss of this
interaction allows the signal generated from the mutant receptor to be sufficient for halo
formation (Konopka and Jenness 1991).
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4. Genetic data from our lab and others suggests that SST2 acts at the level of the G-
protein. gpal- mutation bypasses the a-factor receptor and results in constitutive
activation of the signalling pathway. Recovery from division arest in the gpal- 7 sst2-
mutant is slower than in the sst2- mutant alone which suggests a role for SS12 gene in the
recovery of gpal mutant (Blinder, MCB, 1989). Both STE4 and SS12 are required to stop
the signal from a SteSHyp strain (Hasson et al. 1994). Certain alleles of GPAI bypass the
requirement for a fully active SS12 (Kurjan et al. 1991). Moreover SS12 was found to be
ill
i!'il!li
!IU
.::
lIt
:'!II
~~~, :'
I.,
::;11i
in a complex with GP Al and appears to accelerate the rate of GTP hydrolysis (Dohlman et
,: ,
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aI. 1996).
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Effect of sst2 deletion on Ueand interaction
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1. Does the antagonist DesTrpl,Ala3 a-factor behave like agonist in an sst2L1 strain?
Two findigs suggests that in the sst2 deletion strain, the antagonist behaves like an
agonist. It was shown that an analog of a-factor lacking one amno acid from its
, "1m:
termnus was lO-fold less active in an SST2+ strain and the same molecule was half as
active as a-factor in an sst2- strain (Eriotou-Bargiota et al. 1992). Therefore I asked
whether the antagonist used in the trypsin assay would also lead to the same resu1t. If it
does, then what is the mechanism by which it signals in this strain? Halo assays were
performed with SS12+barl-, sst2-Barl+ and sst2-barl- strains. The results showed that
the DesTrpl , Ala3 a-factor also leads to larger halos in an sst2 deletion background than it
does in the SS12 control strain (Figure 1). Comparing the results of BAR+ and barl-
strains, I conclude that the protease encoded by BARl can not degrade the antagonist as
effciently as it degrades a-factor, since the halos with the antagonist in an sst2- , BARI
are larger than halos with a-factor and the opposite is true in the sst2-barl- strain.
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HALO S ES OF THE DIFRENT STRAS
SST2+ barl- sst2- 1 BARI sst2-1 barl-
1.8 cm 1.15 cm5xlO-5 M a-factor
10-3 M DesTrpl Ala3-a-factor no halo 6cm
5xlO-5 M a-factor 1 cm 8cm
no halo 1 cm10-3 M DesTrpl Ala3-a-factor
Figue 1. Testing the signalling capacity of the sst2 deletion strain with the antagonist used in our
experiments. Strains used were 211- 3 (SST2+ barl- , 3268- 2 ( sst2- 1 BAR1+) and
6360- 17-2 ( sst2- 1 barl- l). The Kc of the anatgonist was determned to be 1 mM from
competition assays. Unlike the halos from the SST2+ strain which have a well-defined
circumference, the edges of the halos wiht the sst2 deletion strain with both the agonist and the
antagonist were hazy. The halo assay with the 6360- 17-2 strain was performed by Ayce Yesilaltay.
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Figure 2. Limited tryptic digestion of the sst2 mutant, (A)
and the wild-type control (8). Membranes w re digested
with trpsin for 5, 10, and 30 min. Reactions included no
ligand (-), antagonist (Des) or agonist (a).
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Trypsin digestion assays were performed for the purpose of probing the mechansm by
which the antagonist signals in an sst2- strain (Figure 2). With the sst2- strai, the
antagonist was not found to expose the third loop as does the agonist, but it also did not
induce the hyperconstraied state that was seen with SS12+ strain. At all time points
1: 
r:41!1i
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tested, the cleavage pattern with the antagonist looked the same as no ligand control. 
was observed with the wild-type receptor, the agonist accelerated the cleavage of the thid
;!ID
::It
loop (formation of F3) in the sst2 deletion strai, and it reduced the cleavag rate in the
termnal domai as judged by the increased accumulation of F 1 and the decreased
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accumulation of F2 at the 5 min time point. This result supports the model summarzed in
Figure 3. In ths model, the hyperconstrained state of the receptor resu1ts from a complex
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of receptor, G-protein and Sst2p, and in an sst2 deletion strain exposure of the thid loop is
not a constraint for activation. Since there are data indicating that Sst2p does not diectly
act on the receptor itself, the effect of Sst2p on the receptor is likely to be more indirect.
Since there are genetic data that suggest Sst2p acts though G-proteins, it is possible that
"III:
Sst2p keeps the Ga~y subunits together and that the binding energy of the antagonist is not
sufficient to dissociate this complex. However, in the sst2 deletion strain, the heterotrimer
is not as strongly associated; consequently, the binding of antagonist is suffcient to
dissociate Ga from G~y and to result in signalling (Figure 3).
2. Does novobiocin potentiate the effects of the antagonist in an sst2L1 background?
Novobiocin is a coumarn antibiotic that targets the DNA gyrase in bacteria. Its mechansm
of action in higher eucarotes is not known. In an attempt to define a target for this drg in
yeast, Pocklington and Orr identified a yeast mutant that was sensitive to this drug. This
phenotype was concluded to be a consequence of a mutation in the SST2 
gene , and it was
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GDP
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HYPER- CONSTRAINED
antagonist
GDP
CONSTRAINED
GDP
CONSTRAINED
Figure 3. Signallng by the antagonist: A. in an SST2+ strain
B. in an sst2 deletion strain
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shown that, in an sst2 deletion strain, novobiocin acts as an agonist for a-cells but not for
a-cells (Pocklington and Orr 1994). Since the results sumarized in the previous section
indicated that in the same strai background the antagonist behaved like an agonist, I
considered the possibility that novobiocin potentiates the activity of the antagonist.
(Eriotou-Bargiota et al. 1992) had shown potentiation of a-factor with a trncated form of
factor which lacks two amo acids from its C-termnus. This work also points to the N-
1MKi
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termnus of a-factor as being important for signalling. Furhermore, the antagonist,
DesTrpl Ala3-a-factor lacks the two trptophans (aromatic residues) in its N-termnus,
:!:'
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and novobiocin has an aromatic strctue (Figue 4) therefore it seemed reasonable to ask
whether the two agents show synergistic activity. I performed halo assays with 
SS12+
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and sst2 deletion strains to test whether cell division arest was caused by antagonist
novobiocin or the two agents together. Although novobiocin produced halos in the 
sst2
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deletion strain and not in the SS12+ strain, the antagonist alone produced larger halos on
its own than in combination with novobiocin. Hence, novobiocin does not complement the
lI'lnm:
defects of the antagonist, DesTrp 1 ,Ala3-a- factor. lft
II. CHARACTERIZATION OF THE ANTAGONIST
There are two types of antagonists; neutral antagonists and inverse agonists (which are also
referred to as negative antagonists as well). Neutral antagonists simply compete for the
binding of agonists and they are thought to have no binding preference for the R or the R 
state. Inverse agonists are ligands that are thought to reduce the activity of the receptor
because they have a higher affinity for the R form of the receptor and stabilize this inactive
conformation. The increase in the affinity of the Ste2- 1274P mutant receptor for the
antagonist suggests that this molecule is an inverse agonist. This is also consistent with the
trypsin assay results from Chapter I (Bukusoglu and Jenness 1996) which show that
binding of the antagonist induces a different conformation of the receptor.
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NC 02 OH
CH 3 
C(CH3)2
"" .& 
NHCO
Figure 4.a. The chemical structure of novobiocin
/; 
OH .
NH2
Figure 4.b. The chemical structure of tryptophan
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1. Is DesTrpl,Ala3-a-factor an inverse agonist of STE2p?
The high level of basal signal afforded by the suppressors of 
ste2- 1274P provide a basis
for futue studies ofthe antagonist DesTrp1,Ala3-a-factor. One propert of inverse
: Ii
\TIIU
::::18,
!II
agonists is that they inhbit the basal level of signalling. As mentioned before, this is not
possible in wild-type yeast due to post-receptor steps generating more noise than with the
\:'
im,
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receptor itself. Since the suppressor mutations of STE2 result in elevated levels of "noise
it should be possible to tu ths off by the addition of inverse agonist but not by neutral
tll:
':::11:
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antagonist. Futue experients with the suppressors should aid the fuer characterization
ofthe DesTrpl,Ala3-a-factor.
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2. Does the antagonist afect the endocytosis of the STE2 receptor?
It was shown that chronic treatment with inverse agonist, but not neutral antagonist
causes 5-HT2C receptor downregulation (Barker et al. 1994). Consistent with this, the
llm:
alB- drenergic receptor internalization was shown to be affected by addition of ligand:
agonist addition resu1ts in the receptor redistribution into endosomes whereas antagonist
prevents this process (Fonseca et al. 1995).
The trpsin digestion data indicate that the DesTrpl Ala3-a-factor used in the assay
could be an inverse antagonist since it induces a conformation that is different than that of
the unliganded receptor. Therefore the effect of the antagonist on endocytosis was
investigated. Renografin gradient centrifugation was used to assay cells for the movement
of the receptor after the cells had been treated with either agonist or antagonist. Results did
not indicate an effect of the antagonist on endocytosis.
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III. EXTRA GENIC SUPPRESSORS
It was curous that although we had set out for extragenic suppressors of the
ste2- 1274P, none was found in this screen. Upon reflection, the design of the screen
might not have ben the best for this purose. The sequence of the intracellular interaction
sites are not altered due to the mutation of residue at 274. Therefore suppressor mutations
that allow the ste2-1274P mutat to mate better because of stabiliation of the R * form of
the mutant receptors are also liely to stabilze the R * form of the wild-tye receptor. Due
to this caveat, the extragenic suppressors of the ste2- T274P 
mutant may not have shown
allele-specificity. Hence, they would have been eliminated in my suppressor screen
(Chapter II.
The work with the extragenic suppressors was cared out as follows:
Afer the mutants were ruled out for bypass suppression, suppression specificity forthe
ste2 12 74 allele was determned. Cross-stamp mating tests indicated that none of the
suppressor mutants were fertile in a ste2 deletion background and all were fertle in the
STE2+ background. Five mutants were fertile when retransformed with plasmid pDJ270
containing the ste2- 1274P but not with pDJ253 containing the ste2-L236H allele. Halo
assays with these five resulted in three different phenotypes:
1. Two suppressors resulted in a slightly larger halo phenotype in the 
STE2+ background
and smaller or same-size clear halos in genetic backgrounds containing either of the 
ste2
alleles.
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2. Ths suppressor (gb 1-3) resu1ted in same size halos for all three alleles of STE2 tested
(the wild-type, the ste2-L236H and ste2- 1274P). Both mutant receptor alleles produced
semi-tubid halos.
3. Two suppressors (gb 10- 13 and 13- 13) resulted in very large halos with wild-type
STE2, larger and clearer halos with ste2- T274P compared to ste2-L236Hbut not as big as i II11:1111'
:1:1l1i
with wild-type STE2+ . i'dll
1,:!JHll
Since the response to pheromone can only be studied in MATa haploid cells, MAT locus
was deleted to faciltate fuer genetic analysis; cells that are mat,1 mate as MATa cells,
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while mat,1 cells that are transformed with a plasmid caring the MATa gene mate as
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MATa cells. The dominance of each suppressor was tested by crossing them to strai
1350-TP (MAT,1::LEU2 ste2-T274P leu2 ura3 ADE2 ade6 trpl cyh2 TYRl+ lys2 his4-
580 SUP4-3 arg4 his3) caring plasmid pDJ102 (YCp MATa , TRPl+). The resulting
diploids were cured of the plasmid; hence, they behaved as MATa maters in the cross-
stamp matig test; five of the diploids tested were ferte. Since the diploids are
,""
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heterozygous for the suppressor mutation, the fact that they are fertile indicates that the
suppressor mutation is dominant. None of the five mutants were specific for ste2-1274P;
nevertheless, fuher characterization of the isolated suppressors might lead to interesting
results. Since most of these mutations result in an enhanced signalling with all the
receptors tested, the suppressor is likely to be in the SS12 gene. Ths could be tested by a
simple complementation experient where the mutant strains can be transformed with a
plasmid caring the SS12 gene.
IV. MORE SIGNALLING MUTANTS
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The screen used to isolate ste2- 1274P was utilzed once more to yield six more a-factor
resistant receptor mutants. With the preliminar binding experiments, of the 118 isolates
tested, these six showed between 30-87% binding to a-factor compared to wild-type
receptor; the rest had close to no binding.
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One of these signalling mutants was found to effect the 258th residue; the proline at ths
position was replaced by a serie (pGB 195). Mutation of the same residue to a leucine was
ii,
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found to lead to constitutive activation (Konopka et al. 1996). It is interesting in this regard
that substitution by a hydrohilic amo acid (serine) results in the opposite phenotype.
i!lW'
:i.:
',;:11:
:'11
This is reminiscent ofthe second site suppressors ofthe ste2- 1274P which when replaced
by a hydrophilic residue afected activation (Chapter II. The difference in the substitution
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of the two amo acids is apparent also from the preliar bindig experiments; whereas
with the constitutively active Pro258Leu receptor, the binding afnity is increased to twice
that of the wild-type, the Pr0258Ser substitution results in decreased affinity (30% of wild-
type). This mutant seems a likely candidate for a receptor that is blocked for allosteric
transition like the ste2-1274P.
The other two mutant alleles that were sequenced do not seem to express a ful-lengt
protein since mutations detected for both resu1t in an opal codon at Gly56 (pGB 134) and
ochre at E135 (pGB 136) although they retain about 50% a-factor binding capacity. The
remaining three mutants have binding abilty ranging from 40-87% (pGB 138, 146 and
218). Further characterization of these receptor mutants is likely to lead to information on
the functional domains of the receptor.
V. IMPROVEMENTS IN THE TRYPSIN DIGESTION ASSAY
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With the present trpsin-digestion assay, ligand-induced conformational changes can be
reliably detected; however, the overall rate of the reaction differs for different membrane
preparations makng it diffcu1t to compare results directly. The time required for trpsin to
complete a given cleavage in the receptor is liely to be limited by the presence of other ::Ii,mill
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"!IIyeast proteins thatcompete for the trsin activity. The quantity and the composition of
these competjng proteins undoubtedly var among the different preparations of parcu1ate
I; il
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fractions used in ths assay. In order to control these competig reactions, wild-type
receptors that have been tagged with six histidinyl residues at the N-termnus wil be used
,1lW
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as internal control. Before the digestion products are resolved on SDS-P AGE, the tagged
standard wil be separated from the untagged test protein by using commercialy avaiable
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spin-columns (Ni-NT A). In this way, the rates of cleavage of mutant receptor can be
compared diectly to the wild-type control. Ths alteration wil alow the comparson of the
conformational states of the varous single and double mutants in the presence and absence
of ligand. Recently, the pheromone receptor was purfied by overexpressing the his-tagged
,111:
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Ste2p (David et al. 1997). The purfication scheme consisted of solubilzing the cell
membranes containing the overexpressed receptor and subjecting it to immobilized metal
affnity chromatography.
The pGAL-His-Ste2 constrct was cloned into pRS304 vector through a two-step,
three way ligation of Bam-EcoRI Gal promoter fragment, EcoRI-ClaI fragment of the
histidine tag, ClaI-KpnI fragment of a truncated STE2. The primers used as the histidine
tag were AATTCATAATGTCTCACCACCATCACCACCACGGTTCCAT and
CGA TGGAACCGTGGTGGTGA TGGTGGTGAGACA TT A TG which were annealed
together and ligated to the vector that had a galactose promoter attached. The ligated
product was digested with EcoRI in order to remove the multimerized inserts that
apparently caused instability in the construct. The insert was sequenced at the U. Mass.
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Nucleic Acid Facilty using the primers P080 and POlll and was integrated into yeast at
the STE210cus by liearing the plasmid pDJ375 with HpaI, transformg strain 211-
and plating it out on -tr+CAA plates. The resulting duplication contains one complete
copy of the STE2 coding sequence fused to the His insert under the control of the GALl
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promoter. The other copy contais trcated STE2 coding sequence under the control of
its own promoter. The strain caring the integration was tested by halo assays on either
'11m,
rich media (lackig galactose) or plates contang galactose; although the constrct
produced halos only on the plates containing galactose (no halos were evident on the YEPD
:;:m,
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plates), the halos were smaler compared to the wild-type strain (211- 3) on galactose
containing plates. The strai (1394- l) was fuher tested by using Western analysis of iil
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crude extracts; the primar antibody recognzes the histidine tag (His-probe fG- 18) from
Santa Cruz Biotechnology, Inc.). Ths antibody failed to produce specific bands with the
His-tagged Ste2 constrct; antibody diected against the C-termal tail of receptor resu1ted
in faint bands. IIUI:
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VI. SERIES OF QUESTIONS
a. To provide fuher evidence for the idea that substitution of the polar residues at the
locations of the suppressors is the reason for the suppression, these residues can be
replaced with more hydrophobic residues which should reverse the phenotype.
b. Amounts of total receptor was found to be about 10% of the wild-type with the
suppressor ste2-A295T. A possible explanation for this could be decreased synthesis or
increased endocytosis of the mutant receptor. Renografin gradients could be used to
differentiate between these possibilties. If it is found that this mutation leads to higher
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basal endocytosis, this would identify a unique residue having a function in both basal
signalling and basal endocytosis.
c. The suppressor mutations alter the expression levels of the receptor protein, therefore
they should be normalized to wild-type by expression through an inducible promoter to
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determe more precisely the increase in their basal level.
11m,
d. It is reasonable to th that the basal endocytosis levels of the ste2- 1274P receptor
would be lower than wild-tye if the mutant receptor was locked in the low afnity form.
:16i
IIml
;161
The assumption here is that the endocytosis signals wou1d be effected in the same way as
the signalling cues in the ste2-1274P. In fact, there is evidence to the contrar; that the 2 11lil
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processes use different signals from Schandel and Jenness (1994) with the non-signalling
receptor mutants where a-factor induced signaling is effected but not endocytosis. Also,
Stefan et.al. (1994) identified a mutant receptor which has 4 amno acid insertons at the C-
termnal par of its thd loop. Although this mutant receptor has higher basal endocytosis
11m:
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compared to wild-type, it did not lead to constitutivity suggesting that signaling and ,
endocytosis signals are different.
e. Is the dominance of the ste2- 1274P more obvious when it is overexpressed?
f. Binding experiments in a gw deletion strain containing the ste2- 1274P allele might
prove useful. If the ste2- 1274P is locked in a low-affnity form that does not couple to G-
proteins (or does so only to a small degree), then the binding of agonist wil not be affected
by gpalL1.
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g. To deduce whether the suppressors of ste2- T274P are global suppressors or not, they
cou1d be tested in combination with other ste2-10ss-of-fuction alleles from our lab (our
unpublished receptor mutants) as well as Konopka and Dumont's receptor mutants; global
suppressors are expected to reverse the phenotype of the otherwise unrelated
loss-of-function alleles. IiiIII.
II,
h. Since the suppressors increase basal levels of signalling, it would be interesting to ask if
they induce basal level of endocytosis.
1m,
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